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ABBREVIATION KEY 
ABC ATP binding cassette 
ANOVA analysis of variance 
AP-1 activated protein-1 
ATP adenosine triphosphate 
BGA brilliant green agar 
BLAST basic local alignment search tool 
BW bodyweight 
C/EBP CCAAT-enhancer-binding protein 
Caco-2 human colorectal adenocarcinoma cell  
Caspase  cysteine-dependent aspartate-directed protease 
CAST Council for Agricultural Science and Technology 
CFU colony forming units 
COX cyclooxygenase 
CREB cyclic AMP response element binding protein 
Ct threshold cycle 
DABCO 1,4-diazabicyclo[2.2.2]octane 
DC dendritic cell 
DMEM Dulbecco’s modified eagle medium 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
DOM-1 de-epoxy-deoxynivalenol 
DON deoxynivalenol 
EFSA European Food Safety Authority 
EGR1 early growth response 1 
eIF2a eukaryote translation initiation factor 2a 
ELISA enzyme-linked immunosorbent assay 
EMA ethidium mono-azide 
ERK  extracellular signal-regulated kinase  
FB fumonisin B 
FCS fetal calf serum 
FHB Fusarium head blight 
FITC fluoresceine isothiocyanate 
gDNA genomic DNA 
gfp green fluorescent protein 
Abbreviation key 
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GM-CSF granulocyte/monocytes-colony stimulating factor 
Go goblet cell 
HCK hematopoietic cell kinase 
HIS histone  
HPRT hypoxanthine-guanine phosphoribosyl transferase 
IBD inflammatory bowel disease 
IC10 inhibitory concentration of 10% 
IFNγ interferon gamma 
Ig immunoglobulin 
IGF insulin-like growth factor 
IGFALS insulin-like growth factor acid labile subunit 
IL interleukin 
IPEC intestinal porcine epithelial cell 
IVET in vivo expression technology 
LB luria broth 
LDH lactate dehydrogenase 
LPS lipopolysaccharide 
LSD least significant difference 
MAPK mitogen-activated protein kinase 
M-cells microfold cells 
MCP-1 monocyte chemotactic protein-1 
MIAME minimum information about a microarray experiment 
MIP macrophage inflammatory protein 
moi multiplicity of infection 
mRNA messenger RNA 
mϕ macrophage 
NCBI National Centre of Biotechnology Information 
NF-κB nuclear factor-kappa B 
nm nanometer 
NOEL no observed effect level 
OD optical density 
Pa paneth cell 
PAK p21 activated kinase 
PAM porcine alveolar macrophages 
PAMPs pathogen associated molecular patterns 
Abbreviation key 
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PBS phosphate buffered saline 
PCR polymerase chain reaction 
PEEC pathogen-elicit-epithelial-chemoattractant 
PGE-2 prostaglandin E2 
P-gp P-glycoprotein 
PI plasmocyte secreting immunoglobulin A 
PKR RNA-activated protein kinase 
PMA phorbol myristate acetate 
PMN polymorphonuclear 
PMTDI provisional maximum tolerable daily intake  
PP Peyer’s patch 
PRRs pattern recognition receptors 
RNA ribonucleic acid 
rpm rotations per minute 
SAPK/JNK stress-activated protein kinase/c-Jun N-terminal kinase  
SCOOP Scientific corporation on questions relating to food 
SCV Salmonella containing vacuole 
SGLT1 D-glucose/D-galactose sodium dependent transporter 
Sif Salmonella induced filaments 
SOCS suppressors of cytokine signaling 
sp species 
SPI Salmonella pathogenicity island 
T3SS type three secretion system 
TDI tolerable daily intake 
TEER transepithelial electrical resistance 
Th T helper 
TLR toll-like receptor 
TNFα tumor necrosis factor alpha 
v/v volume/volume 
VAP vacuolar-associated actin polymerization 
w/v weight/volume 
wt wild type 
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1. The mycotoxin issue in food and feed 
 
Mycotoxins are secondary metabolites of filamentous fungi, which can contaminate many 
types of food crops throughout the food and feed chain. Mycotoxin producing fungi can be 
divided into two groups: field fungi such as Fusarium species that produce mycotoxins in the 
field, whereas storage fungi (Aspergillus and Penicillium) occur after harvest. In some cases 
like unusually hot and dry conditions, Aspergillus and Penicillium sp. can also affect crops 
during the growing season. On the other hand, field fungi can continue growing and 
producing mycotoxins during transport and storage (www.mycotoxins.org).  
Many factors are involved in the production of mycotoxins on cereal crops, with 
environmental conditions such as temperature and moisture being of utmost importance in 
both pre- and/or post-harvest stages (Figure 1).  
 
 
Figure 1: Factors affecting mycotoxin occurrence in the food chain (Council for Agricultural Science and 
Technology (CAST), 2003).  
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Their global importance as a potential risk factor for both animal and human health should not 
be neglected as it is estimated that one quarter of the world’s crop production would be 
contaminated with mycotoxins (Fink-Gremmels, 1999; Oswald et al., 2005).  
In a recent paper, Binder et al. (2007) reported the results of a two-year survey program 
undertaken to evaluate the incidence of mycotoxins in feed and feed raw materials. A total of 
2,753 assays were performed on 1,507 samples taken from European and Mediterranean 
markets for the determination of aflatoxin B1, ochratoxin A, deoxynivalenol, T-2 toxin, 
zearalenone and fumonisins. Fifty-two percent of these samples were tested positive, with 
DON, zearalenone and T-2 toxin as major contaminants, indicating that the incidence of 
mycotoxins is quite high in animal feed.  
The growing awareness that mycotoxins are a significant concern to human and animal 
health, has in many countries led to regulations of levels of mycotoxins in food and animal 
feedstuffs (van Egmond et al., 2007). In Europe, maximum allowed levels for food and feed 
have been set up by European Commission Regulations and Recommendations. An overview 
of the current legislation can be found at the website of the European Food Safety Authority 
(EFSA, http://efsa.europa.eu). The EFSA is the keystone of European Union risk assessment 
regarding food and feed safety. EFSA’s Panel on Contaminants in the Food Chain 
(CONTAM) provides risk managers with scientific advice to inform their decision-making on 
the setting of maximum levels of mycotoxins (such as ochratoxin A, deoxynivalenol or 
zearalenone) in food and feed. It estimates the related risks posed to human and animal health 
and may set tolerable daily intake levels for various mycotoxins. With regard to mycotoxins 
in feed, the CONTAM Panel also considers the level of carry-over from feed to foods of 
animal origin and identifies feed materials which could be considered as sources of exposure.  
A correct evaluation of mycotoxin contamination in food and feed is of utmost importance in 
determining the compliance with the acceptable safety standards. Because of the often highly 
heterogeneous distribution of mycotoxins in so-called ‘hot-spots’ in the food, the most critical 
stage is taking a representative sample. Therefore appropriate sample plans are essential to 
ensure that the analytically derived mean concentration of a sample is representative to the 
true mean concentration of a lot (Whitaker et al., 2005; Milićević et al., 2010; Chaytor et al., 
2011). 
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Mycotoxin contamination of food and feed chain has a major economic impact. In addition to 
crop losses and reduced animal productivity, costs are derived from the efforts made by 
producers and distributors to counteract their initial losses, the costs of improved technologies 
for production, storage and transport, analytical testing and sampling plans, especially as 
detection and regulations become more and more stringent (Whitaker et al., 2005).  
Fusarium species are the most prevalent mycotoxin producing fungi in Europe due to their 
preference for the weather conditions existing in this region. Infection of crops by these fungi 
can lead to Fusarium head blight (FHB) in small grain cereals and although this results in 
reduced yield, the major concern referred to FHB is the presence of mycotoxins. 
Trichothecenes, zearalenone, fumonisins and moniliformin are the most important mycotoxins 
produced by Fusarium fungi. Among the trichothecenes, deoxynivalenol (DON), which is 
mainly produced by F. graminearum, is the predominant mycotoxin (McMullen et al., 1997). 
It is generally accepted that rainfall just before and during flowering of the crop, which is 
situated around June, favours FHB pathogens. Recently, it was demonstrated that the weather 
conditions during winter might also influence the survival of primary inoculums in soil, 
weeds and crop residues (Landschoot et al., 2011a,b). As Fusarium mycotoxins are produced 
within the growing crop, agricultural practices such as maize as previous crop, minimum 
tillage after maize and use of a moderate sensitive or susceptible wheat variety, can affect the 
mycotoxin contamination of the crop (Obst et al., 2000; Edwards, 2004). Also climate 
changes might contribute to the Fusarium incidence and coinciding DON contamination in 
cereal grains (Paterson and Lima, 2010; Pestka, 2010). Although the implementation of good 
agricultural practices helps to reduce the risk for Fusarium epidemics, the application of 
fungicides remains the most important control measure to reduce Fusarium symptoms. Where 
the effect of fungicides on fungal outgrowth is quite straightforward, several reports suggest 
that the application of some fungicides not automatically results in a corresponding reduction 
in mycotoxin contamination (Edward, 2004; Medina et al., 2007; Zhang et al., 2009a,b; 
Audenaert et al., 2011). Of particular interest is the fact that exposure of Fusarium to sub 
lethal concentrations of fungicides might stimulate mycotoxin production. Audenaert et al. 
(2010) demonstrated using an in vitro approach that exposing F. graminearum to sub lethal 
doses of prothioconazole resulted in proliferated production of DON by inducing an oxidative 
stress in the fungus. At long-term, the adaptation ability of fungi to stress, can lead to 
mutations or adaptations that can give rise to more aggressive crop pathogens (Audenaert et 
al., 2011). 
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A large-scale collaborative study by the Scientific Corporation on Questions relating to Food 
(SCOOP) assessed the frequency with which predominantly cereal-based foods (44,670 food 
items) from European Union members states were contaminated by Fusarium mycotoxins. 
Eleven countries provided data on the levels of DON on a subtotal of 11,022 food samples. 
Overall, DON was the most frequently observed mycotoxin, and 57% of all samples tested 
were contaminated. Moreover, the report suggested that for some individuals, particularly 
children, exposure may exceed the maximum tolerable daily intake (TDI) of 1 µg/kg 
bodyweight/day (European Commission, 2003; Schothorst and van Egmond, 2004). The 
maximum levels for DON set down by the European Commission for cereals and cereal based 
products, vary from 1.75 mg/kg for unprocessed wheat to less than 0.2 mg/kg in processed 
cereals based foods for infants and young children (European Commission, 2007).  
The importance of DON in feed matrices was recently illustrated by the analysis of 82 
samples of 3 different feed matrices in Europe (sow feed, wheat and maize). This resulted in 
the detection of 67 contaminated samples of which 52 contained DON in concentrations 
varying from 74 to 9528 µg/kg (Monbaliu et al., 2010). In swine production, cereal grains 
account for 55 – 70% of the total feed mixture as they represent the main source of energy 
(NRC, 1998). With the pig being the most sensitive species to the effects of DON and 
Fusarium mycotoxins in general, contamination of swine feed can seriously affect the health 
and economic stability of swine production. The guidance value for DON in complementary 
and complete feeding stuffs for pigs was set at 0.9 mg/kg, as described in the Commission 
Recommendation of 17 August 2006 (2006/576/EG) (Table 1; European Commission, 2006).  
 
 
 
 
 
 
 
 
 
General introduction 
 
11 
 
Table 1. The guidance values on the presence of deoxynivalenol, zearalenone, ochratoxin A, T-2 and HT-2 and 
fumonisins in products intended for animal feeding, as determined in the Commission Recommendation of 17 
August 2006 (2006/576/EG). 
 
Mycotoxin Products intended for animal feed Guidance value 
in mg/kg (ppm) 
relative to a feedingstuff 
with a moisture content of 
12% 
Deoxynivalenol  Feed materials (*) 
- -Cereals and cereal products (**) with the exception of 
maize by-products  
- -Maize by-products 
Complementary and complete feedingstuffs with the 
exception of: 
-Complementary and complete feedingstuffs for pigs 
-Complementary and complete feedingstuffs for calves       
( < 4 months), lambs and kids 
 
8 
 
12 
 
5 
0.9 
2 
Zearalenone Feed materials (*) 
-cereals and cereals products (**) with the exception of 
maize by-products 
-maize by-products 
Complementary and complete feedingstuffs 
-complementary and complete feedingstuffs for piglets and 
gilts 
-complementary and complete feedingstuffs for sows and 
fattening pigs 
-complementary and complete feedingstuffs for calves, 
dairy cattle, sheep (including lamb) and goats (including 
kids) 
 
2 
 
3 
 
0.1 
 
0.25 
 
0.5 
Ochratoxin A Feed materials (*) 
-cereals and cereal products (**) 
Complementary and complete feedingstuffs: 
-complementary and complete feedingstuffs for pigs 
-complementary and complete feedingstuffs for poultry  
 
0.25 
 
0.05 
0.1 
Fumonisin A+B Feed materials (*) 
-Maize and maize products (**) 
Complementary and complete feedingstuffs for: 
-pigs, horses (Equidae), rabbits and pet animals 
-fish 
-poultry, calves ( < 4 months), lambs and kids 
-adults ruminants ( > 4 months) and mink 
 
60 
 
5 
10 
20 
50 
 
(*)Particular attention has to be paid to cereals and cereal products fed directly to the animals that their use in a 
daily ration should not lead to the animal being exposed to a higher level of these mycotoxins than the 
corresponding levels of exposure where only the complete feedingstuffs are used in a daily ration.  
(**)The term ‘cereals and cereal products’ includes not only the feed materials listed under heading 1 ‘Cereal 
grains, their products and by-products’ of the non-exclusive list of main feed materials referred to in part B of 
the Annex to Council Directive 96/25/EC of 29 April 1996 on the circulation and use of feed materials (OJ L 
125, 23.5.1996, p.35) but also other feed materials derived from cereals in particular cereal forages and 
roughages.  
(***)The term ‘Maize and maize-byproducts’ includes not only the feed materials derived from maize listed 
under heading 1 ‘Cereal grains, their products and by-products’ of the non-exclusive list of main feed materials 
referred to in part B of the Annex to Council Directive 96/25/EC of 29 April 1996 on the circulation and use of 
feed materials (OJ L 125, 23.5.1996, p.35) but also other feed materials derived from cereals in particular cereal 
forages and roughages. 
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2. The mycotoxin deoxynivalenol 
 
2.1. Chemical structure 
Trichothecene mycotoxins are a large group of structurally related sesquiterpenoid 
metabolites. All trichothecenes have a 9,10 double bond and a 12,13-epoxy group in common, 
the latter related to their toxicity. Depending on their functional groups, trichothecenes have 
been classified into A, B, C and D groups (Figure 2). Members of group A do not contain 
carbonyl on C-8 (e.g. T-2 toxin). Group B differs from group A by the presence of a carbonyl 
group on C-8 (e.g. DON). Group C members have another epoxy group between the C-7 and 
C-8 or C-8 and C-9 positions, respectively (e.g. crotocin). Compounds in group D include a 
macrocyclic ring between C-4 and C-15 (e.g. satratoxin) (Wu et al., 2010).  
 
 
Figure 2: Chemical structures of trichothecenes with examples from groups A to D (Wu et al, 2010). 
 
DON is very stable at temperatures up to 350 °C. Due to this stability during processing and 
cooking, DON can easily enter the food and feed chain with potential to cause human and 
animal toxicity (Pestka and Smolinski, 2005; Bullerman and Bianchini, 2007). 
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2.2. Mechanisms of toxicity 
2.2.1. Molecular mode of action 
Trichothecenes to which DON belongs, have multiple inhibitory effects on eukaryote cells 
including inhibition of protein synthesis, DNA and RNA synthesis, inhibition of 
mitochondrial function, effects on cell division and membrane effects (Rocha et al., 2005). 
The molecular target of trichothecenes in leucocytes and actively dividing cells is the 60s 
ribosomal subunit. After diffusion through the cell membrane, trichothecenes are able to bind 
eukaryotic ribosomes and interfere with peptidyltransferase function with consequent 
impairment of initiation and elongation and inhibition of protein synthesis.  Apart from this 
ribosome binding, other possible mechanisms involved in the translation inhibition by DON 
are suggested, with the ability of DON to promote degradation of 28S rRNA being the most 
studied one. The disruption of the function of the 3’-end of the 28S rRNA by DON is 
followed by an inhibition of the protein synthesis since this region of the ribosome is 
functional in aminoacyl-tRNA binding, peptidyltransferase activity and ribosomal 
translocation (Ueno, 1985, 1988; Uptain et al., 1997).  
The capacity of specific ribosome-directed stressors to damage 28S rRNA by interfering with 
its functioning during gene translation, can lead to what has been called ‘ribotoxic stress 
response’. These ribosome-directed stressors cover ribosome-inactivating proteins including 
ricin, saporin from plants and shigatoxin from bacteria but also non-protein ribotoxic stressors 
including ultraviolet radiation, trichothecene mycotoxins and anisomycin antibiotics 
(Iordanov et al., 1997; Laskin et al., 2002; Moon, 2012). Most characteristic biochemical 
patterns of cellular responses to ribotoxic stress are the activation of mitogen-activated protein 
kinases (MAPKs) and their downstream targets. Activation by DON of the MAPKs 
extracellular signal-regulated kinases (ERK1/2), stress-activated protein kinase/c-Jun N-
terminal kinase 1 and 2 (SAPK/JNK1/2) and p38 results in the subsequent activation of 
downstream transcription factors such as nuclear factor kappa B (NF-κB), Activating Protein 
(AP)-1, CCAAT-enhancer-binding protein (C/EBP), cyclic AMP Response Element Binding 
protein (CREB) and Early Growth Response 1 (EGR1) gene product, all of which are 
important in driving critical cellular processes such as cell proliferation and differentiation, 
inflammation and apoptosis but also for transcriptional activation of pro-inflammatory 
mediator expression (Iordanov et al., 1997; Shifrin and Anderson, 1999; Chang and Karin, 
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2001; Zhou et al., 2003a; Pestka, 2005; Bae and Pestka, 2008; Van De Walle et al., 2010a; 
Moon, 2012).  
A schematic summary of the molecular mode of action of DON is illustrated in Figure 3. 
 
Figure 3: Molecular mode of action of deoxynivalenol (DON). After entry into the cell, DON binds to the large 
ribosomal subunit transducing a signal to PKR and HCK. As a result of this ribotoxic stress response, MAPKs, 
including ERK1/2, SAPK/JNK1/2 and p38,  pathways are initiated. This MAPKs activation leads, depending on 
the DON dose, to an increased pro-inflammatory cytokine gene expression or leucocyte apoptosis resulting in 
anorexia and reduced weight gain, immune stimulation and inflammation, tissue loss and dysfunction, and 
immunosuppression, respectively (adapted from Riley and Pestka, 2005). 
 
It was shown that trichothecenes are able to induce the phosphorylation of two putative 
kinases identified as upstream transducers of the MAPK activation, namely RNA-activated 
protein kinase (PKR) and hematopoietic cell kinase (HCK) (Pestka et al., 2004). Both play a 
potential role in the early steps in the ribotoxic stress response as they associate constitutively 
with ribosomes and possibly sense the damage induced by DON to rRNA (Zhou et al., 2003b; 
Pestka et al., 2004; Pestka, 2010).  
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2.2.2. Neuropharmacological effects 
The reduction of the feed consumption (anorexia) at low concentrations and the induction of 
vomiting (emesis) at higher acute doses are two biological activities associated with the intake 
of DON, especially in pigs. An altered neuroendocrine signaling within the nervous system at 
the central and enteric level appears to be involved in these effects. The serotoninergic system 
has been demonstrated to play a role in both the anorectic response and the emetic response. 
Intragastric dosing of pigs with DON led to a significant and prolonged increase in cerebral 
fluid concentration of the major metabolite of serotonin, indicating an enhanced turnover of 
this neurotransmitter, which is known to be implicated in neural processes underlying feeding 
behavior at central level. The possible link between DON-induced emesis and the 
serotoninergic mechanism was proven as pretreatment with selective serotonin receptor 
blockers indeed blocked the DON-induced vomiting in pigs (Prelusky and Trenholm, 1993). 
Apart from the direct effect of DON on the central nervous system, it was speculated that a 
part of DON’s mechanism of action is mediated through the action on the peripheral serotonin 
receptors found in the gastrointestinal tract (Fioramonti et al., 1993; Prelusky, 1993). Indeed 
much of the body’s serotonin is produced and released by enterochromaffin cells in the gut 
where it acts in a paracrine way on the terminals of vagal efferent neurons of the enteric 
nervous system (Li, 2007). Recently it was described using a mouse model that in addition to 
a peripheral action, after per os administration DON can reach the brain and act centrally 
resulting in impairment of anorexigenic balance by interfering with central neuronal networks 
involved in food regulation (Girardet et al., 2011b). In addition, the upregulation of IL-1β, IL-
6 and TNFα mRNA within central structures involved in food intake control, seen after per os 
administration of DON might explain the DON-induced anorexia (Girardet et al., 2011a). The 
DON-induced conditioned taste aversion to other constituents present in feed was studied in 
rats and it was found that this was mediated by the area postrema, a circumventricular organ 
on the fourth ventricle of the brain which has been functionally associated in a range of 
physiological and behavioral processes (Borison, 1989; Ossenkopp et al., 1994). Using 
crystalline DON, complete feed refusal was seen at levels of 12 mg DON per kg feed and 
vomiting at 20 mg/kg feed (Forsyth et al., 1977; Young et al., 1983). However, several 
studies indicate that naturally infected feed led to more pronounced effects on feed intake and 
weight gain than pure toxin. A possible explanation could be the presence of other toxins or 
other compounds in the material affecting the toxicity of trichothecenes and inducing taste 
aversion (Rotter et al., 1996). 
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2.3. Effects at the gastrointestinal level 
The gastrointestinal epithelium functions as a dynamic barrier regulating on the one hand the 
uptake of nutrients and water but on the other hand preventing the entry of luminal antigens 
into the underlying tissues (Oswald, 2006). DON usually enters the body through the 
ingestion of contaminated food or feed and therefore intestinal epithelial cells can be exposed 
to high concentrations of the toxin (Maresca et al., 2002; Bouhet and Oswald, 2005; Sergent 
et al., 2006). Since DON is known to be an effective protein synthesis inhibitor, the constant 
renewing intestinal epithelium may be particularly sensitive to the toxic effects of DON 
(Instanes et al., 2004).  
 
2.3.1. Effects on the intestinal epithelial cell-derived innate defence mechanisms 
Intestinal epithelial cells are known to participate in the intestinal innate immune system by 
different mechanisms, which can be classified as intrinsic or extrinsic of nature. A continuous 
monolayer of intestinal epithelial cells firmly joined together by intercellular structures 
including tight junctions, adherence junctions and desmosomes at the apical region of cells 
accounts for the intrinsic component of the intestinal immunity (Gumbiner, 1993). In addition 
to this physical barrier, intestinal epithelial cells have developed a number of extrinsic defense 
mechanisms including mucus secretion, defensins and antibacterial peptide synthesis and 
secretion of cytokines and chemokines. Each of them is of great importance in reducing the 
risks of exposure of intestinal epithelial cells to both invasive pathogens and damaging toxic 
compounds (Oswald, 2006). The diverse effects of DON on intestinal epithelial cells have 
been studied using both in vitro diverse intestinal epithelial cell lines as ex vivo and in vivo 
experimental setups. 
Enterocytes may be exposed to DON either from the luminal or from the basolateral side. The 
luminal exposure especially accounts for the duodenum and the first parts of the jejunum but 
when absorbed, DON can reach the enterocytes in the more distal regions via the systemic 
circulation (Danicke et al., 2010). In contrast with in vitro cell culture experiments, where the 
cells are exposed continuously to DON, enterocytes in vivo appear thus not to be exposed to 
DON in a continuous manner but rather to time-dependent fluctuations as the absorption of 
DON is nearly completed 3 to 4 hours after the consumption of a DON containing meal 
(Danicke et al., 2004; Goyarts et al., 2006). It is thus clear that the effects of DON in vitro 
might not completely reflect the situation in vivo because of the much larger number of 
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processes interacting in processing the ingesta (Danicke et al., 2010; Maresca and Fantini, 
2011).  
Figure 4 gives an overview of the effects of DON on the local defence mechanisms of 
intestinal epithelial cells. Deregulation of this immune homeostasis of the gut may contribute 
to the development of intestinal inflammation. 
+- - - +
 
Figure 4: The effects of DON on the local defence mechanisms of intestinal epithelial cells. IEC : intestinal 
epithelial cells, PI: plasmocyte secreting immunoglobulin A (= IgA), Go: goblet cell; Pa: paneth cell (adapted 
from Bouhet and Oswald, 2005). 
 
Cell viability, proliferation and intestinal morphology  
Considering the effects of DON on intestinal cell proliferation and intestinal morphology, 
alteration of the cell differentiation with structural and functional characteristics after 
exposure to low concentrations of DON was shown in the human colonic adenocarcinoma cell 
lines Caco-2 and T84 (Kasuga et al., 1998). Using intestinal porcine epithelial cells (IPEC)-1 
and IPEC-J2 cell culture models, the toxic effects of DON appeared to be time- and dose-
dependent, with high concentrations DON inducing toxic effects compromising the intestinal 
barrier integrity whereas low concentrations modulated the cellular regulation (Diesing et al., 
2011). Dose-dependent alterations in the histology of pig jejunal explants were observed after 
exposure to DON, including shortening and coalescence of villi, lysis of enterocytes and 
edema (Kolf-Clauw et al., 2009).  
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Cell homeostasis and viability can also be severely compromised by oxidative damage. 
Although DON treatment inhibited cell proliferation in human colon carcinoma cells, the 
toxin did not induce heat shock protein expression nor oxidative damage (Bensassi et al., 
2009). On the other hand, a genotoxic potential for DON at low non-cytotoxic concentrations 
was demonstrated in human cells lines and this was caused by direct DNA fragmentation 
leading to p53 and caspase-dependent apoptosis (Bony et al., 2006; Bensassi et al., 2009). 
 
Mucus production 
Goblet cells present in the crypt and villus of the intestinal epithelium form a continuous 
mucus layer lining the apical side of intestinal epithelial cells. This mucus, which consists of 
mucins associated with proteins and lipids, protects the epithelium not only against the 
adhesion and invasion by pathogens but also to physical and chemical attacks (Montagne et 
al., 2004). A reduction of the number of mucus-producing goblet cells and of the tightness of 
the intestinal glycocalyx was seen in pigs exposed to low concentrations of mixtures of DON, 
T-2 toxin and zearalenone (Obremski et al., 2008).  
 
Production of antimicrobial substances 
Another extrinsic mechanism of mucosal defence occurs by the secretion of agents exhibiting 
antimicrobial properties by paneth cells and intestinal epithelial cells (Pitman and Blumberg, 
2000). Most of these antimicrobial molecules are cationic and act by disrupting the integrity 
of the microbial membranes (Bouhet and Oswald, 2005). They include bactericidal peptides 
or proteins such as defensins, cathelicidins, angiogenins as well as the antimicrobial enzyme 
lysozyme and phospholipase A2 (Müller et al., 2005). There are no studies available 
describing the effect of mycotoxins on the secretion of intestinal antimicrobial peptides. 
The secretory immunoglobulin (Ig) pathway represents a further form of extrinsic resistance 
to foreign pathogens present within the lumen. IgA is secreted from mucosal plasma cells 
present in the sub-epithelial space across mucous membranes of the intestinal, respiratory, 
genital and biliary tract. Following its release into the lumen, secreted IgA can participate in 
immune exclusion by inhibiting bacteria to associate with the epithelial surface (Pitman and 
Blumberg, 2000; Bouhet and Oswald, 2005). It is known that trichothecenes can modulate the 
serum concentration of IgA (Pestka, 2003), but their effect on intestinal secreted IgA has not 
been investigated yet.  
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Barrier function  
An important aspect of the toxic effects of DON on the enterocyte border is the toxin’s ability 
to disrupt the epithelial barrier integrity, resulting in an enhanced permeability of the cell 
layer with potential intestinal disorders as a consequence. The determination of the 
transepithelial electrical resistance (TEER) in in vitro cell monolayers serves as a good 
indication of epithelial integrity and of the degree of organization of the tight junctions 
(Hashimoto and Shimizu, 1993).  
Several studies using human cell monolayers indicate that long term treatment with cytotoxic 
doses of DON compromises tight junctions which is indicated by a drop in TEER and an 
increase in the passage of paracellular tracers such as FITC-dextran (Kasuga et al., 1998; 
Maresca et al., 2002, 2008; Sergent et al., 2006; Pinton et al., 2009, 2010). Consequently this 
increased intestinal permeability caused by high doses of DON (up to 100 µM) may allow the 
transepithelial passage of both non-invasive commensal bacteria (Maresca et al., 2008) as of 
pathogenic Escherichia coli, as was demonstrated using IPEC-1 cell monolayers (Pinton et 
al., 2009). Apart from the DON induced cytotoxic effect and the inhibition of the protein 
synthesis described in human enterocytes (Kouadio et al., 2005, 2007; Van De Walle et al., 
2010b), these alterations in the barrier function may coincide with a specific reduction in the 
expression of claudins which was demonstrated in vitro using IPEC-1 and Caco-2 cells and 
confirmed in vivo using jejunal explants of pigs exposed to DON contaminated feed (Pinton et 
al., 2009, 2010). It is described that the structure and function of tight junctions such as 
claudin can be regulated by signaling molecules involved in MAPKs cascades (Matter and 
Balda, 2003). Since DON is known to activate these MAPKs pathways (Pestka et al., 2004), 
exposure to the toxin may explain the decreased expression of tight junction proteins with 
subsequent reduction of the barrier function. However, Maresca et al. (2008) also showed a 
significant increase in bacterial passage through Caco-2 cells exposed to lower concentrations 
of DON (10 µM) that did not compromise the barrier function. In this context, it could be 
speculated that, exposure to apparently non-cytotoxic concentrations of DON could render the 
intestinal epithelium more vulnerable for enteropathogenic bacteria, including invasive 
pathogens such as Salmonella Typhimurium. 
 
Secretion of cytokines and chemokines  
As reviewed by Oswald (2006) intestinal epithelial cells are able to secrete cytokines and to 
respond to exogenous chemokines which are crucial elements for the recruitment and the 
activation of immune cells.  
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In response to mucosal ribotoxic stress, as encountered after intake of DON contaminated 
food or feed, the intestinal epithelium transmits the danger signals to the underlying 
lymphocytes and antigen-presenting cells by releasing pro-inflammatory chemokines such as 
IL-8. Induction of epithelial pro-inflammatory cytokines by trichothecenes appears to be 
independent on NF-κB signaling pathway in the intestinal epithelia. Indeed, promotion of IL-
8 production and its positive modulator early growth response gene 1 (EGR1) was seen in 
human epithelial intestinal 407 cells after treatment with DON, indicating that EGR1 is 
involved in the pro-inflammatory IL-8 gene expression in the DON treated intestinal 
epithelial cells (Moon et al., 2007). EGR1-mediated IL-8 production could also be addressed 
in association with the transcription factors NF-κB, AP-1 and C/EBP since these partially 
contribute to ribotoxin-induced cytokine transcriptional activation (Moon, 2012). In Caco-2 
cells a dose-dependent increase in IL-8 production and prostaglandin E2 (PGE-2) 
synthesizing capacity was described (Van De Walle et al., 2008, 2010a), and this was linked 
to the activation of ERK1/2 (Moon et al., 2007) and PKR, p38 and NF-κB inflammatory 
cascades (Maresca et al., 2008).  
IL-8 is a pro-inflammatory chemokine that regulates the attraction and trafficking of 
neutrophils during the acute phase of inflammation. Prostaglandins such as PGE-2 regulate 
vascular dilatation, mucosal secretion and generate fever and are thus important mediators in 
inflammatory responses (Borish and Steinke, 2003). The NF-κB transcription factor activates 
the transcription of many inflammatory genes including cytokines and chemokines such as 
TNFα and interleukins (Ahn et al., 2007; Magalhaes et al., 2007).  
In addition to its direct effect on IL-8 secretion, DON is also able to potentiate the action of 
other pro-inflammatory stimuli as described for IL-1β in human enterocytes (Maresca et al., 
2008) and lipopolysaccharide (LPS) in the mouse (Islam and Pestka, 2006).  
The ability of DON and mycotoxins in general to induce intestinal inflammation can thus be 
either indirect through alterations of the intestinal epithelial barrier and the crossing of 
luminal antigens, or direct by the secretion of pro-inflammatory cytokines by the intestinal 
epithelium (Maresca et al., 2008).  
 
2.3.2. Effects on epithelial transport systems  
After exposure to mucosal ribotoxic xenobiotics, such as trichothecenes, gut epithelia employ 
defensive transporters to excrete the toxins. Indeed, efflux transporters play a key role in 
disposition and excretion of many substances, including dietary contaminants such as 
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mycotoxins. The known efflux transporters in the intestine mostly belong to the ATP-binding 
cassette (ABC) transporter superfamily which includes the multidrug resistance protein-1 
(MDR1) or P-glycoprotein (P-gp), multidrug resistance-associated proteins (MRPs) and the 
breast cancer resistance protein (BRCP). Intestinal epithelial cells can use ABC transporters 
such as P-gp and MRP2 to export ribotoxic trichothecenes (Tep et al., 2007; Videmann et al., 
2007). Conflicting reports have been published on the role of ABC transporters in DON 
transfer. Sergent et al. (2006) suggested that DON crossed the intestinal mucosa in a 
paracellular way which was not affected by P-gp nor MRP inhibitors. On the other hand, 
Videmann et al. (2007) demonstrated that DON represented a substrate for both P-gp and 
MRP2, leading to a transcellular transport through the intestinal epithelial barrier.  
Moreover, ribotoxic xenobiotics also modulate nutrient transporting by interfering with 
various nutrient transporter systems which might account for the malnutrition and weight loss 
in exposed animals. The effect of DON on the uptake of nutrients was studied in the human 
epithelial intestinal cell line HT-29-D4 and indicated that DON selectively affected the 
activities of the intestinal transporters including the D-glucose/D-galactose sodium-dependent 
transporter (SGLT1), the passive D-fructose transporter GLUT5 and the active and passive L-
serine transporter and that this may be due to the ability of DON to induce apoptosis through 
protein synthesis inhibition, as was shown by mimicking these effects using cycloheximide 
(Maresca et al., 2002). Studies in broilers fed low to moderate dietary concentrations of DON 
indicated a specific inhibitory effect of the toxin on glucose transport in addition to a 
concurrent decrease of intestinal surface area with shortening and thickening of villi (Awad et 
al., 2007, 2008b, 2011). It is rather surprising that poultry performance is not or only 
moderately affected by the intake of DON contaminated feed. As it is known that chickens are 
able to absorb D-glucose and amino acids even from the large intestine, it is possible that by 
the decrease of nutrient absorption in the proximal small intestine, a part of the uptake is 
transferred to the more distal parts, where the absorptive functions may be more protected 
against the deleterious effects of DON (reviewed by Awad et al., 2008a). 
 
2.3.3. Effects on intestinal microflora 
An enormous number of micro-organisms are known to colonize the intestine and form 
complex communities or microbiota. The host-microbiota associations usually evolve into 
beneficial relationships, where bacteria present in the gastrointestinal tract supply key 
nutrients and prevent colonization by opportunistic pathogens. The stability of the intestinal 
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microflora is thus of great importance as an impaired balance could have many adverse 
effects on the health of the host.  
Ribosome-inactivating stressors, such as trichothecene mycotoxins are generally known to be 
effective in blocking eukaryotic 28S rRNA and thus, theoretically do not interfere with 
bacterial protein translation. Although many in vitro screening and microbial analyses have 
identified intestinal bacterial strains that contribute to trichothecene detoxification  (He et al., 
1992; Eriksen et al., 2002; Niderkorn et al., 2006; Young et al., 2007), only a few studies 
have looked at the action of ribotoxic stress on the gut bacterial population and its activity. In 
pigs and rats, it was shown that administration of T-2 toxin for one week caused a substantial  
increase in the aerobic intestinal bacteria count (Tenk et al., 1982). A recent investigation 
using DON demonstrated a slight but statistically significant increase in the aerobic 
mesophilic bacteria count in DON-exposed piglet colon. Although there was no effect of 
DON on microbial diversity, the richness index, which was based on the microbial numbers, 
was significantly increased by DON exposure (Wache et al., 2009b). The mechanisms by 
which T-2 toxin, DON and other ribotoxic stressors affect the gut bacterial composition are 
however still unclear.  
 
2.4. Effects on immune system 
Numerous studies, both in vitro and in vivo have determined that the immune system is 
extremely sensitive to trichothecenes and for DON this effect can be either 
immunostimulatory or immunosuppressive, depending on the dose of DON, the exposure 
frequency, and the type of the functional immune assay (Pestka and Smolinski, 2005). 
Inflammation is a rapidly occurring non-specific response which leads to the activation of 
macrophages and neutrophils and subsequent secretion of cytokines, arachidonic acid 
metabolites and active oxygen and nitrogen compounds by these activated phagocytes. 
Macrophages play an essential role in both the innate and acquired immune response. The 
effect of DON on macrophages has been described in several in vitro and in vivo studies. 
Exposure of macrophages to low doses of DON may lead to an increase in the production and 
secretion of inflammatory cytokines (Wong et al., 1998; Doll et al., 2009), whereas high 
doses of DON induce macrophage apoptosis (Zhou et al., 2005). DON also inhibits IFNγ 
mediated human macrophage activation and this could contribute to a decrease of host 
resistance to several pathogens after exposure to DON (Wache et al., 2009a). 
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The immune stimulating effect of low doses of DON relates to the ability of the mycotoxin to 
induce gene upregulation (Pestka, 2008) which can be due to either an increased mRNA 
stability (Wong et al., 2001) or an increased transcription factor activity linked to 
phosphorylation of MAPKs (Zhou et al., 2003a; Pestka et al., 2004). In vitro and in vivo 
experiments on murine immune cells exposed to DON showed an activation of critical 
transcription factors including e.g. NF-κB and activator protein-1 (AP-1) (Ouyang et al., 
1996; Li et al., 2000; Wong et al., 2002) and upregulation of their downstream targets such as 
cyclooxygenase-2 (COX-2) (Moon et al., 2003), IL-1β, IL-2, IL-4, IL-5, IL-6 (Dong et al., 
1994; Azcona-Olivera et al., 1995; Wong et al., 1998) and TNFα (Wong et al., 1998; Chung 
et al., 2003). Exposure of human lymphocytes to DON also led to an increased expression of 
IL-2, IL-4, IL-6, IL-8 and TNFα (Meky et al., 2001; Sugita-Konishi and Pestka, 2001). In 
pigs, after an acute intravenous exposure to DON, a temporary recruitment of neutrophils in 
the peripheral blood by IL-8 and subsequent activation of the bactericidal function was seen, 
together with the transient increase in pro-inflammatory cytokines and acute-phase proteins 
(Mikami et al., 2011).  
The effect of DON on the antibody synthesis is manifested by an elevation in serum 
immunoglobulin (Ig) A and concurrent depression of IgM and IgG. Concomitantly with the 
increase in serum IgA, an elevation in IgA immune complex and polymeric IgA appears and 
this may be mediated by T-lymphocytes and macrophages especially through the 
superinduction of cytokine genes such as IL-2, IL-5 and IL-6 (Pestka, 2003; Oswald et al., 
2005). In mice this DON-induced immunopathology closely mimics the human 
glomeronephritis IgA nephropathy (Pestka, 2003).  
High doses of DON promote the rapid onset of leucocyte apoptosis with concomitant immune 
suppression. Using macrophage and monocyte models it was shown, that in analogy with the 
gene upregulation, DON-mediated apoptosis correlates with activation of the MAPKs families 
(Yang et al., 2000).  
The consequences of this DON-induced suppressed immune function may involve decreased 
resistance to infectious diseases, possible reactivation of chronic infections and decreased 
vaccine and drug efficacy (reviewed by Oswald et al., 2005). It was shown using a pig model 
that chronic consumption of DON contaminated feed impaired the immune response during a 
vaccination protocol as demonstrated by the alteration of the antibody response, the 
lymphocyte proliferation and the cytokine expression in the lymph nodes (Pinton et al., 2008). 
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In mice acute DON exposure impaired the immune response to respiratory reovirus infection 
by suppression of IFN-mediated responses, upregulation of pro-inflammatory cytokine and 
chemokines expression and elevated IgA responses in the lung (Li et al., 2006). 
 
2.5. Implications for pig’s health  
In farm animals including poultry and ruminants, intoxication following the consumption of 
cereals and cereal-derived products contaminated with DON results in feed refusal and 
reduced weight gain, leading to growth retardation with great economic consequences 
(Girardet et al., 2011b).  
Numerous toxicological studies have been performed in diverse animal species in order to 
elucidate the toxin’s mode of action and potential hazardous effects. Differences in 
absorption, distribution, metabolism and excretion of DON among the animal species may 
account for the species sensitivity to toxin’s effects (Trenholm et al., 1984). Among all animal 
species evaluated, the pig is shown to be the most susceptible species to the effects of DON, 
following the ranking order pigs > mice > rats > ruminants ≈ poultry (Rotter et al., 1996).  
 
2.5.1. Toxicokinetics of DON in pigs  
In pigs, the absorption of DON after oral administration is rapid with an oral bioavailability 
around 80% and reaching peak plasma concentration within 15 – 30 minutes after ingestion 
(Prelusky et al., 1988). Although the toxin is extensively absorbed only a small proportion of 
the dose can be found in the blood. Depending on the studies the plasma elimination half-life 
was found to vary between 1.2 and 3.9 hours (Prelusky et al., 1991; European Commission, 
2004).  
In a study by Prelusky et al. (1988) 
14
C-labeled DON was given intragastrically to pigs at a 
dose of 0.6 mg/kg bodyweight or intravenously at a dose of 0.3 mg/kg of bodyweight and 
blood, urine, bile and feces were collected over 24 hours. Urine is the major excretory route 
for both intravenously and orally applied DON. About 95% of the administered dose was 
recovered as unchanged DON, and no glucuronide conjugates of DON were found, although a 
glucuronide-conjugate metabolite was found with the treatment of urine and bile samples with 
β-glucuronidase. Two and a half percent of the dose was found to be excreted by the bile, 
20% through the feces and 68% with urine. An efficient urinary excretion indicates indeed a 
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high gastro-intestinal absorption while a high fecal elimination might be due to an efficient 
biliary excretion or a lack of systemic absorption (Goyarts and Danicke, 2006).  
The main metabolites of DON in pigs are de-epoxy-DON (DOM-1) and glucuronide-
conjugated DON (Figure 6).  
 
 
Figure 6. Metabolism of DON in animals (adapted from Wu et al., 2010). 
Prelusky et al. (1988) concluded from the small increase in the DON level seen after 
incubation with β-glucuronidase that only small amounts of the toxin are present as the 
glucuronide conjugate metabolite in pigs. Conjugation with activated glucuronic acid 
proceeds in the endoplasmatic reticulum, particularly in the liver as a reaction to enhance the 
water solubility and to facilitate the excretion with the urine or bile. However, there appeared 
to be a difference between the route of administration, as following oral administration, 9.1 – 
60% of total DON was found to be conjugated in the serum whereas after intravenous 
administration no DON glucuronide conjugates were present (Goyarts and Danicke, 2006). As 
phase II enzymes accounting for the conjugation are also widespread in extrahepatic tissues 
e.g. gastrointestinal tract, it could be hypothesized that DON is conjugated in the intestine 
before absorption and that glucuronide-conjugated DON is not as toxic as free DON possibly 
because it does not fit into the activation centre of the 60S ribosomal subunit and is eliminated 
faster with the urine (Goyarts and Danicke, 2006). 
DON can be metabolized to the non-toxic DOM-1 in the gut, especially in the caudal 
segments. This was illustrated by anaerobic incubation of DON with suspensions of intestinal 
contents (duodenum, jejunum, cecum, colon, rectum) from porcine origin for 24 hours. The 
caudal segments and the colon content in particular showed stronger metabolic activity 
whereas the microorganisms of the cranial segments exhibited no transforming activity 
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(Kollarczik et al., 1994). These findings were confirmed in vivo in pigs that were fed a diet 
containing 4.2 mg/kg DON over a period of 7 days (Danicke et al., 2004). No DOM-1 was 
detected in serum and only traces in the stomach and small intestine, whereas notable amounts 
of the metabolite were found in the distal segments of the gut. It was suggested that this de-
epoxidation probably does not contribute much to the toxin’s detoxification in pigs as it 
mainly occurs in the large intestine and the majority of the ingested DON is already absorbed 
in the proximal part of the small intestine (Danicke et al., 2004).  
Residue analysis of DON in tissues from pigs fed DON concentrations ranging between 0.7 to 
7.6 mg DON/kg feed revealed in most cases low (< 20 µg/kg) or undetectable DON 
concentrations (European Commission, 2004). 
 
2.5.2. Acute toxic effects 
Although DON is one of the less toxic trichothecenes compared to e.g. T-2 toxin, extremely 
high doses of DON can cause shock-like death. In sensitive animal species, symptoms of 
acute DON toxicity include abdominal distress, increased salivation, malaise, diarrhea, emesis 
and anorexia (Pestka, 2007).  
A single dose of DON as little as 0.05 mg/kg bodyweight intraperitoneally and 0.1 – 0.2 
mg/kg bodyweight orally was described to cause vomiting in pigs (Forsyth et al., 1977). 
Another study showed that emesis in pigs occurs within minutes after ingestion of feed 
containing 19.7 mg/kg, which correlates with the intake of 150 µg/kg bodyweight/day of 
DON. On the other hand, emesis was not detected when the pigs were fed 11.9 mg/kg 
suggesting that the no observed effect level (NOEL) for emesis in pigs was 120 µg/kg 
bodyweight/day based on average daily intake data (Young et al., 1983). For this effect to 
occur via a contaminated feed, it is likely that the DON dose must be presented in a single 
meal rather than small amounts ingested throughout a day. 
 
2.5.3. Chronic toxic effects 
In most monogastric species, subchronic and chronic exposure to DON leads to growth and 
weight gain suppression. 
Porcine experimental models showed that prolonged dietary exposure to DON results in 
decreased weight gain, anorexia and altered nutritional efficiency (Rotter et al., 1996). It was 
reported that DON at 1 – 2 mg/kg caused partial feed refusal in pigs ingesting naturally 
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contaminated feedstuffs, whereas 12 mg/kg caused complete feed refusal (Forsyth et al., 
1977; Young et al., 1983; Rotter et al., 1994). A dose dependent decrease of weight gain in 
the first eight weeks was described when pigs were fed a diet containing 2 and 4 mg/kg of 
DON, with the highest concentration causing a decreased feed intake and feed utilization 
efficiency throughout the experiment (Bergsjo et al., 1992). Similar effects on feed intake and 
weight gain were seen in castrated male pigs fed diets with 3 mg/kg of DON. However there 
appeared to be a difference between the intake of naturally contaminated feed ingredients 
versus feed spiked with purified DON which might be due to the presence of additional toxins 
and fungal components in naturally contaminated grains contributing additionally or 
synergistically to the effect of DON (Prelusky et al., 1994). 
When pigs were fed 3.5 mg/kg of DON, an increase in liver weight, decreased serum protein 
and albumin levels and temporary drop in serum calcium and phosphorus was seen, in 
addition to a significantly decreased bodyweight, decreased slaughter weight and reduced 
feed utilization efficiency (Bergsjo et al., 1993).  
Other clinical effects that were described when DON was incorporated in pig’s diets are 
reduction in thyroid size, increased thyroxine levels and morphological changes in the 
esophageal region of the stomach (Rotter et al., 1994). DON fed in combination with 
zearalenone, was reported to significantly reduce oocyte quality with possible implications for 
reproduction (Alm et al., 2006). Changes in the histology of the liver (glycogen decrease, 
hemosiderin enhancement, interlobular collagen uptake, increased fatty and autophagic 
vacuoles) were also described although changes in serum transaminases levels, indicating 
liver damage, were not observed (Tiemann et al., 2006). 
 
2.6. Implications for men’s health 
The potential impact of DON on human health may occur after ingestion of contaminated 
foods from oats, barley, wheat, maize or other grains but also flour, bread, noodles, beer and 
malt may contain DON. Indeed, several epidemiological studies have reported acute illnesses 
including vomiting, abdominal pain, diarrhea, dizziness in populations who have consumed 
Fusarium contaminated grains. Outbreaks of human food poisoning associated with the 
ingestion of DON contaminated food such as scabby wheat, barley and moldy maize have 
been described in Japan, China and India (Bhat et al., 1989; Pestka and Smolinski, 2005). As 
illustrated by the large scale results from the SCOOP report, the levels and patterns of human 
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food commodities contamination justify that DON consumption constitutes a major issue for 
global public health. Wheat and wheat containing products like bread and pasta represent the 
major source of intake for DON. Estimated daily intake of DON ranges from 0.3 to 2 µg/kg 
bodyweight/day in European Union countries (European Commission, 2003; Schothorst and 
van Egmond, 2004). 
Given the capacity of DON to evoke toxicity in animals, accurate exposure assessment is 
necessary to understand the potential for adverse health effects in both farm animals and 
humans (Riley et al., 2011). In this context, the development of adequate biomarkers is an 
emerging issue. Biomarkers are defined as measurable biochemical or molecular indicators of 
either exposure or biological response to a specific mycotoxin. Mechanism-based biomarkers 
often include changes in the level of specific proteins, cellular metabolites, or gene expression 
resulting from specific alterations in metabolic or signaling pathways. Exposure-based 
biomarkers, on the other hand, are most often the mycotoxin itself or the metabolized 
mycotoxin by-product such as glucuronide conjugates (Baldwin et al., 2011; Riley et al., 
2011). Based on the observation that DON is conjugated with glucuronic acid in the liver, 
DON-glucuronide can be used as a biomarker of exposure in human populations (Meky et al., 
2003; Turner et al., 2008). Urinary DON levels were also shown to be a sensitive exposure 
biomarker and a valuable tool for biomonitoring as part of surveillance strategies and in 
etiologic studies of DON and human disease risk. Moreover, there appeared to be a positive 
correlation between the urinary levels of DON and the cereal intake, particularly bread 
consumption (Turner et al., 2008). Relative to these biomarkers of effect, other approaches in 
developing biomarkers for DON exposure were proposed, as illustrated in Figure 7. Although 
pro-inflammatory cytokines seem an obvious choice, they can be induced by many stressors 
and chemical agents, making them rather non-selective relative to DON. However, these pro-
inflammatory cytokines are known to induce several suppressors of cytokine signaling 
(SOCS) of which some impair the growth hormone signaling, leading to growth retardation. 
Hepatic SOCS3 mRNA is suggested as a particular sensitive indicator for DON exposure 
although the need for an invasive procedure such as a liver biopsy might hamper the practical 
use. The hepatic upregulation for SOCS3 co-occurs with a downregulation of hepatic insulin-
like growth factor acid labile subunit (IGFALS) and a reduction in circulating insulin-like 
growth factor 1 (IGF1) and IGFALS levels, suggesting the latter could serve as biomarkers of 
effect in populations exposed to DON (Amuzie et al., 2010; Pestka, 2010; Riley et al., 2011).  
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Figure 7: Metabolism and aspects of the mode of action of DON and potential biomarkers of exposure and 
effect (adapted from Amuzie et al., 2010; Riley et al., 2011). 
Interestingly, there appears to be mechanistic evidence that ribotoxic stress-induced cellular 
response are implicated as critical etiological factors of mucosa-associated diseases, in 
particular epithelial inflammatory diseases (Moon, 2011, 2012). The term “chronic intestinal 
inflammatory diseases” covers many human diseases characterized by a dysregulated immune 
response in the gut of genetically predisposed patients. Celiac disease and inflammatory 
bowel diseases such as ulcerative colitis and Crohn’s disease are the best known. Although 
apart from a genetic predisposition, the definite causes of the diseases are still unclear, there 
are three widely accepted etiological hypotheses in terms of the epithelial pathogenesis: 1) 
chronic persistent microbial activation and imbalance of microbial diversity and dominance; 
2) disruption of mucosal barrier including epithelial junction and mucosal defence; 3) 
abnormal immune regulation such as excessive activation of mucosal immune response and 
insufficient suppressor function (Moon, 2012). In this context, a potential link between 
exposure to some food-associated mycotoxins including DON and human chronic intestinal 
inflammatory diseases, such as celiac and Crohn’s disease or ulcerative colitis has been put 
forward. At realistic concentrations, DON has been shown to modulate key intestinal 
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functions involved at the onset and during the progression of chronic intestinal inflammatory 
diseases, as is illustrated in Figure 8 (Maresca and Fantini, 2010).  
One can thus state that there is solid evidence for the potential health implications of fairly 
low exposure to DON and that there is an urgent need to define the human risk from this 
foodborne contaminant. 
 
 
Figure 8: Intestinal alterations caused by the exposure of mycotoxins in relation to the induction and/or 
persistence of human chronic intestinal inflammatory diseases. Mycotoxins can 1) cause gene mutations in the 
enterocytes, 2) modify the intestinal flora, 3) alter the production and the composition of the mucus layer, 4) 
increase the transepithelial bacterial passage through an increased transcellular passage and/or to an increase in 
the intestinal permeability due to tight junction defects, 5) modulate the pro-inflammatory cytokine secretion by 
the intestinal epithelium e.g. IL-8, 6) increase the secretion of IgA directed against microflora and autoantigens, 
7) disturb the Th1/Th2 immune response balance (adapted from Maresca and Fantini, 2010). 
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3. Salmonella Typhimurium infections in pigs 
 
3.1. The genus Salmonella 
Salmonella is a Gram-negative facultative intracellular pathogen that causes a spectrum of 
clinical diseases depending on the infecting bacterial serovar and the underlying host 
susceptibility. Salmonella spp. are ubiquitous in nature recovered from nearly all vertebrates 
from amphibians, reptiles to birds and mammals, posing both an animal health and a food 
safety problem. The genus Salmonella is divided into two species: Salmonella bongori and 
Salmonella enterica.  
Salmonella bongori resides primarily in reptiles and infrequently causes disease in 
endothermic animals. The species Salmonella enterica contains over 2,500 serovars and there 
are two main clinical syndromes associated with Salmonella enterica infection: non-typhoidal 
salmonellosis or a gastrointestinal disease also known as enteritis, and typhoid fever, a 
systemic disease characterized by fever, intestinal perforation and hemorrhage, enlargement 
of the mesenteric lymph nodes, spleen and liver (Valdez et al., 2009).  
Depending on their host restriction, Salmonella serotypes can be divided in: (1) serotypes 
capable of causing typhoid-like disease in a single host species (host-restricted serotypes, e.g. 
Salmonella Typhi in humans); (2) serotypes associated with one host species but also able to 
cause disease in other hosts (host-adapted serotypes, e.g. Salmonella Choleraesuis in pigs); (3) 
the vast majority of the remaining serotypes which rarely produce systemic infections but are 
able to colonize the alimentary tract of a wide range of animals (broad host range serotypes, 
e.g. Salmonella Typhimurium). 
Salmonella enterica can cause fatal disease in domestic animals, with severe economic losses 
and can persist undetected in food animals causing a serious problem for the food industry 
because of food poisoning (Mastroeni and Grant, 2011).  
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3.2. Importance of salmonellosis for human and animal health 
Salmonella species have been recognized as human and animal pathogens for over a century. 
A recent study estimated that approximately 94 million human cases of gastroenteritis and 
155,000 deaths occur due to Salmonella infections around the world each year (Majowicz et 
al., 2010). Farm animals and foods of animal origin form an important source of human 
Salmonella infections.  
Salmonella Enteritidis and Salmonella Typhimurium are the most frequently reported 
serovars constituting around 75% of all confirmed cases of human salmonellosis. In the 
period 2006 to 2009, the porcine reservoir, next to the laying hen reservoir was estimated to 
be the second largest contributor to human salmonellosis in the EU responsible for 26.9% of 
the reported cases. Moreover it was shown that in eight countries, including Belgium, pigs 
were even the most important source of infection (Biohaz, 2010; Pires et al., 2011). The 
Salmonella Report 2010 of CODA-CERVA, which acts as Belgian reference laboratory for 
Salmonella, indicated that in pigs Salmonella Typhimurium isolates were found in 67.5% of 
the Salmonella positive samples analyzed (Anonymous, 2010). Pigs can thus be a major 
reservoir of Salmonella and the potential of Salmonella infection in slaughter pigs to translate 
into Salmonella contamination of pig meat can lead to transmission through the food chain 
resulting in human infection and disease (European Commission, 2008). 
A variety of clinical manifestations have been observed in Salmonella infected pigs, ranging 
from no disease to peracute disease. Infections with Salmonella Typhimurium usually cause 
mild or no disease, however these subclinically infected animals may shed the bacteria for 
considerable periods of time with stress factors such as transport and lairage even enhancing 
this excretion (Berends et al., 1996; Boyen et al., 2006).  
Salmonellosis in pigs poses thus a double threat since it not only causes economic losses due 
to animal weakening and underproduction but also due to the public health risk 
commercializing Salmonella infected pork products (Boyen et al., 2008; Collado-Romero et 
al., 2010). 
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3.3. The pathogenesis of Salmonella Typhimurium infections in the pig 
An infection with Salmonella Typhimurium generally occurs in three stages: 1) the 
colonization of the gut and adhesion to the intestinal wall, 2) the invasion of the gut wall and 
3) the dissemination to mesenteric lymph nodes and other organs.  
A schematic overview of the pathogenesis is given in Figure 9.  
 
 
Figure 9: Pathogenesis of a Salmonella Typhimurium infection (Sansonetti, 2004).  
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3.3.1. The intestinal phase of infection 
Several routes of transmission of Salmonella have been described, including airborne 
transmission, but the fecal - oral route of infection appears to be the most important one in 
pigs. In order to reach the small intestines, Salmonella must overcome various antimicrobial 
barriers with the porcine epithelial beta-defensin 1 expressed at the dorsal tongue surface and 
oral epithelium being the first one (Shi et al., 1999). Subsequently, the acidic environment of 
the stomach represents a significant bottleneck to infection although salmonellae dispose of 
an adaptive acid-tolerance response when exposed to low pH (Giannella et al., 1972; Ohl and 
Miller, 2002). After emerging from the stomach and entering the small intestine, the presence 
of high concentrations of bile in the duodenum may repress the invasion pathway of 
Salmonella, although the bacterium is able to adapt to high bile concentrations (Prouty and 
Gun, 2000). The presence of resident microbial flora might also provide benefit to the host, 
including niche protection from pathogens, although Salmonella appears to be able to create 
specific growth conditions in the intestinal lumen which enables it to outcompete the resident 
microbiota (Santos et al., 2009). 
After entering the small intestines, salmonellae must traverse the intestinal mucus layer before 
encountering and adhering to the intestinal epithelial cells. The adhesion, generally accepted 
as the first step in the pathogenesis of Salmonella infections in pigs, is a complex mechanism 
and several fimbriae, mainly type 1 fimbriae, contribute to the ability of Salmonella to adhere 
to intestinal epithelial cells (Ohl and Miller, 2002; Althouse et al., 2003). Moreover, a recent 
study showed that also the Salmonella Pathogenicity Island (SPI)-1 encoded type III secretion 
system (T3SS) effectors SipB, SipC and SipD act in concert to mediate the intimate 
association of Salmonella Typhimurium with host cells required for T3SS mediated protein 
delivery (Lara-Tejero and Galan, 2009). 
Following the adhesion, the invasion into host cells is a next critical step in the pathogenesis 
of Salmonella and this can occur through several routes, as illustrated in Figure 9 (Sansonetti, 
2004). Salmonella can invade non-phagocytic epithelial cells by a process called bacterial-
mediated endocytosis after which the bacterium becomes enclosed within an intracellular 
phagosomal compartment known as the Salmonella-containing vacuole (SCV) allowing 
bacterial survival and multiplication (McGhie et al., 2009). Being located subepithelial, 
Salmonella can then either invade enterocytes basolaterally or disseminate systemically. 
Salmonella can also cross the Microfold (M-) cells of the follicle-associated epithelium 
mainly located in the Peyer’s patches (PP) followed by the uptake in dendritic cells (DC) and 
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macrophages in the subepithelial compartment. An alternative route of invasion that doesn’t 
involve M-cells is the direct capture of Salmonella from the luminal content by a population 
of phagocytes that protrude pseudopods between the enterocytes. Some bacteria can even 
bypass the PPs and disseminate to the spleen and liver directly from the intestinal lumen, 
being transported by the blood within CD18
+
 cells (Mastroeni and Grant, 2011).  
In addition to invasion of the intestinal epithelial barrier, Salmonella induces a secretory 
response in the intestinal epithelium and initiates recruitment and transmigration of 
neutrophils into the intestinal lumen, which is mainly regulated by the epithelial cell 
production of IL-8 (Ohl and Miller, 2002). The massive neutrophil influx in the intestine is 
the histopathological hallmark of Salmonella Typhimurium induced enterocolitis in humans 
and animals (Tukel et al., 2006). The possible mechanism leading to neutrophil infiltration in 
the intestinal mucosa is not clear yet. One hypothesis states that by injecting effector proteins 
into the host cytosol, Salmonella Typhimurium triggers this host response, which induces a 
pro-inflammatory gene expression profile in the intestinal epithelium. The second hypothesis 
proposes that as a result of the bacterial invasion of the intestinal epithelium, pathogen-
associated molecular patterns (PAMPs) are recognized through pathogen recognition 
receptors (PRRs) expressed by epithelial cells and mononuclear cells in the lamina propria, 
which leads to the activation of the innate pathways of inflammation. As reviewed by Tukel et 
al. (2006), it appears that while PRRs are clearly involved in eliciting neutrophils influx 
during Salmonella Typhimurium infection, a direct contribution of effectors in triggering pro-
inflammatory host cell response cannot be ruled out.  
 
3.3.2. The systemic phase of infection 
After the invasion process is completed, Salmonella serotypes associated with systemic 
illness, spread from the gastrointestinal tract to the bloodstream using the host macrophage to 
establish the systemic infection. In pigs however, the systemic part of a Salmonella 
Typhimurium infection is poorly documented and colonization in pigs is mostly limited to the 
gastrointestinal tract (Boyen et al., 2008). Being located inside the macrophage, Salmonella is 
shielded from the elements of the humoral immunity although the phagosome also exposes 
the bacterium to a nutrient poor and antimicrobial environment, since the phagosomal 
environment is acidic and contains antimicrobial peptides, oxygen and nitrogen radicals that 
can damage the bacterial cell (Rathman et al., 1996; Mastroeni et al., 2000; Haraga et al., 
2008). These phagosomal conditions activate many of the regulators that are implicated in 
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salmonellae virulence, permitting the bacterium’s survival and replication in the intracellular 
environment (Ohl and Miller, 2002; Bader et al., 2003; Haraga et al., 2008). Using the blood 
stream and lymphatic fluids, the infected macrophages can then migrate throughout the body 
and colonize other organs of the reticuloendothelial system such as mesenteric lymph nodes, 
spleen and liver initiating prominent systemic and local immune response. 
 
3.3.3. Carrier state of infection and prolonged fecal shedding 
Although Salmonella Typhimurium generally causes no or mild disease in pigs, asymptomatic 
carriers are thought to represent the most important source of Salmonella introduction onto 
pig farms (Hoelzer et al., 2011). In subclinical carrier pigs it was demonstrated that the tonsil 
is the primary site of colonization suggesting that, although the presence of low numbers of 
Salmonella Typhimurium within the tonsil may provide a continuous stimulation of the 
immune system, its response may not be sufficient to clear the bacteria from the host resulting 
in the development of a carrier state (Wood et al., 1989, Wood and Rose, 1992; Gray et al., 
1995). The difficulty to detect the carrier state in pigs by bacteriological and serological 
methods may affect the monitoring programs (Boyen et al., 2008). Moreover, it is known that 
stress factors such as lairage and transport not only induce Salmonella carriers to start 
shedding again but also turn Salmonella-free pigs more susceptible to infection (Williams and 
Newell, 1970; Berends et al., 1996). Although in mice Salmonella virulence genes were 
identified that play a role in the development of the carrier state and long-term shedding, the 
role of these genes could not be confirmed in the pig, leaving underlying mechanisms unclear 
(Boyen et al., 2006).  
Using in vivo expression technology (IVET), Van Parys et al. (2011) were the first to identify 
37 genes specifically induced in porcine tonsils, ileum and ileocaecal lymph nodes at 3 weeks 
post-oral inoculation as an indication of genes involved in Salmonella persistence in these 3 
different organs of pigs. 
 
3.3.4. Salmonella pathogenicity islands 
The ability of Salmonella to invade in non-phagocytic host cells and then to survive and 
replicate within the SCV determines the bacterium’s virulence and is mediated by 
chromosomally encoded virulence genes, which are clustered in several SPIs (Steele-
Mortimer, 2008; Valdez et al., 2009). The two primary SPIs are SPI-1 and SPI-2.  
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Both SPI-1 and SPI-2 encode T3SS which are specialized needle-like devices used to inject 
bacterial effector proteins directly into the host cell cytoplasm. These proteins have the 
capacity to modulate a variety of cellular functions, including cytoskeleton dynamics, 
vesicular trafficking, cell cycle progression, programmed cell death and transcription (Lara-
Tejero and Galan, 2009). 
The translocation of effectors via the SPI-1 encoded T3SS allows Salmonella Typhimurium to 
enter non-phagocytic cells of the intestinal epithelium through modulation of the actin 
cytoskeleton dynamics. The T3SS encoded by SPI-2, which is structurally and functionally 
distinct from that of SPI-1, and whose expression is induced upon bacterial internalization, 
modulates vesicular trafficking and is essential for the bacterial growth and replication within 
a variety of host cells, including macrophages and dendritic cells. By delivering proteins 
inside the SCV or through the vacuolar membrane into the host cytosol, the SPI-2 T3SS 
effector proteins appear to interfere with the maturation of the SCV, preventing phagosome-
lysosome fusion and allowing Salmonella to physically avoid the microbiocidal effectors 
within the macrophage (Marcus et al., 2000; Ohl and Miller, 2002; Steele-Mortimer, 2008; 
McGhie et al., 2009).  
 
3.3.5. Role of the actin cytoskeleton in Salmonella pathogenesis 
The actin cytoskeleton mediates a variety of essential biological functions in all eukaryotic 
cells. Apart from determining shape and motility of the cell, it is involved in crucial cellular 
processes.  
 
3.3.5.1. Involvement of actin cytoskeleton in Salmonella invasion 
The ability of Salmonella spp. to invade into M-cells and cells that are normally non-
phagocytic such as intestinal epithelial cells, involves a complex series of cytoskeletal 
changes induced by translocated effector proteins (Guiney and Lesnick, 2005).   
The organization of the host actin cytoskeleton is controlled by the Rho-family of small 
GTPases. As illustrated in Figure 10, the activation of the host Rho GTPases Cdc42 and Rac 
by the SPI-1 T3SS effector proteins SopB, SopE and SopE2 leads to the stimulation of 
downstream signaling pathways which not only activate the actin cytoskeleton reorganization 
but also lead to the stimulation of the transcription factors NF-κB and AP-1 and to the 
production of pro-inflammatory cytokines (Haraga et al., 2008).  
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The formation of membrane ruffles, which is a typical characteristic of Salmonella invasion, 
is the result of the interaction between the bacterial effector proteins SopB, SopE and SopE2 
and actin filaments, promoting macropinocytosis and engulfment of Salmonella in the SCV. 
Together with this G protein activation, two actin-binding proteins SipA and SipC are 
translocated into the host cell to promote actin polymerization and bundling of F-actin at the 
site of bacterial invasion. The cellular responses stimulated by Salmonella are transient and 
after bacterial entry, the cell regains its normal architecture. This process is mediated by SptP 
which exerts its function by serving as a GTPase activating protein for Cdc42 and Rac, 
turning these G proteins off after their stimulation by the bacterial effectors SopE and SopB, 
helping in restoring the actin cytoskeleton to its normal dynamics (Galan and Zhou, 2000; 
Galan, 2001; Murli et al., 2001).  
 
 
Figure 10: Model for Salmonella Typhimurium interaction with cytoskeleton of host cells (Haraga et al., 2008).   
 
3.3.5.2. Actin cytoskeletal events associated with intracellular infection 
Within several hours after infection of host cells, a F-actin network assembles around the 
replicative SCV (Steele-Mortimer, 2008). This focal condensation of actin filaments (VAP or 
vacuolar-associated actin polymerizations) around the vacuole appears a morphological 
feature of the SCV and is induced by a SPI-2 dependent mechanism (Guiney and Lesnick, 
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2005). Although the role of these VAPs during the intracellular pathogenesis is not clear yet, 
they may help in creating a more favorable environment for the bacteria. The migration of the 
SCV during its maturation towards the perinuclear region of the host cells appears of great 
importance for promoting bacterial replication. Once the SCV is positioned, the intracellular 
replication of Salmonella is characterized by the formation of specialized tubulovesicular 
structures known as Salmonella-induced filaments (Sifs) (Steele-Mortimer, 2008).  
Taken together, Salmonella is able to target cellular actin by a series of interactions, 
promoting bacterial uptake into host cells and the subsequent proliferation and intercellular 
spread of the bacteria.  
 
3.3.6. The interaction of Salmonella Typhimurium with macrophages 
The persistence of Salmonella within cells of the reticuloendothelial system has long been 
accepted as a key stage in the pathogenesis of the bacterium (Watson et al., 2000). 
Salmonellae can enter macrophages by several endocytic processes, including SPI-1 and non-
SPI-1 T3SS-induced macropinocytosis. Once intracellular, salmonellae remain inside a 
vacuolar compartment, which has been named the spacious phagosome. The spacious 
phagosome shrinks to form an adherent membrane around one of more bacteria, and is then 
referred to as the SCV (reviewed by Haraga et al., 2008). Apart from using macrophages to 
spread throughout the host’s body during the systemic phase of infection by establishing an 
intracellular niche within the phagocytic vacuole, Salmonella Typhimurium can also induce 
host-cell death, providing a potential mechanism by which Salmonella can escape from an 
infected cell to infect neighboring cells.  
Programmed cell death or apoptosis is a fundamental mechanism to eliminate infected or 
damaged cells. It is characterized by the condensation of the nucleus and the cytoplasm, and 
fragmentation of the cell. This leads to the formation of apoptotic bodies which are then 
eliminated by the macrophages in order to prevent the release of noxious cellular contents 
(Fink and Cookson, 2007). Salmonella has been described to trigger two general mechanisms 
leading to different types of programmed cell death in macrophages, although the biological 
and immunological importance of these different types of cell death and their contribution to 
the pathogenesis of Salmonella or host defense is not clear yet (Guiney, 2005; Figure 11).  
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Figure 11: Pathways leading to the induction of macrophage cell death by Salmonella (Guiney, 2005). 
 
The first pathway is mediated both by effector proteins delivered by SPI-1 TTSS and SipB 
which leads to the activation of caspase-1 inducing rapid cell death by a mechanism that 
shares features of both necrosis and apoptosis, and the release of IL-1β and IL-18. Recently 
Miao et al. (2010) demonstrated for the first time that caspase-1 clears intracellular bacteria in 
vivo independent of IL-1β and IL-18. The resulting pyroptosis, which is pro-inflammatory due 
to the rapid loss of cell membrane integrity and release of cytosolic content, appears an 
efficient mechanism of bacterial clearance by the innate immune system.  
The second pathway involves the activation of Toll-like receptor (TLR) 4 by PAMPs leading 
to the initiation of a complex signal transduction cascade (Hsu et al., 2004). Downstream 
activation of kinase pathways leads to balanced pro- and anti-apoptotic regulatory factors in 
the cell. NF-kB and p38 MAPK are particularly important for the induction of anti-apoptotic 
factors, whereas the kinase PKR which is required for bacterial-induced apoptosis, 
phosphorylates the eukaryote translation initiation factor 2A (eIF2a), leading to inhibition of 
protein synthesis. The balance of all these apoptosis regulatory factors determines whether the 
cell will survive or enter the programmed cell death pathway, with caspase-3 as the major 
executioner of the characteristic apoptotic changes. 
Salmonella that are not causing a SPI-1 dependent rapid cell death can still trigger a delayed 
SPI-2 dependent cell death. The Salmonella SPI-2 T3SS is essential for altering the balance in 
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favor of apoptosis during intracellular infection. The infected, apoptotic cells are targeted for 
engulfment by incoming macrophages, thus perpetuating the cycle of cell-to-cell spread that is 
the hallmark of systemic Salmonella infection. Although the effectors involved in this delayed 
apoptosis are poorly characterized, SpvB has been suggested to play a role in apoptosis in 
human macrophages by depolymerizing the actin cytoskeleton (Lesnick et al., 2001; Kurita et 
al., 2003). Also the stimulation of TLR4 and the dsRNA responsive kinase PKR may be 
involved in this delayed from of salmonella-induced macrophage cell death (Hsu et al., 2004). 
It is however not clear whether macrophage cell death is triggered by salmonella to counteract 
host defence mechanisms or whether it constitutes a host response to halt bacterial replication 
(Hueffer and Galan, 2004). 
 
3.3.7. Innate immune control of Salmonella Typhimurium 
The outcome of a Salmonella infection is determined by both bacterial and host factors, 
including the virulence of the infecting Salmonella serotype, and the ability of the host to 
establish an efficient inflammatory and immune response in order to destroy the pathogen 
(Eckman and Kagnoff, 2001).   
Intestinal epithelial cells play an important role in the innate immune response. Not only do 
they serve as a physical barrier, they are also able to produce signaling molecules through 
recognition of PAMP (e.g. LPS, peptidoglycan, mannose and flagellin) by toll-like receptors 
(Zeng et al., 2003; Arce et al., 2010; Collado-Romero et al., 2010). Most of these signaling 
molecules are chemokines which attract diverse cell types to the subepithelial regions after 
Salmonella infection. These cells include leucocytes such as neutrophils, monocytes and 
macrophages (e.g. by IL-8 and monocyte chemotactic protein-1, MCP-1) but also specialized 
subsets of T-cells and immature DC (Eckmann and Kagnoff, 2001). In addition to this 
basolateral release of chemokines, hepoxilin A3, formerly known as pathogen-elicited-
epithelial-chemoattractant (PEEC), is released apically by the epithelial cells, attracting 
neutrophils across the epithelium into the gut lumen (McCormick et al., 1998; Mrsny et al., 
2004). The intestinal epithelium also releases other cytokines that can enhance the local host 
defense by activating phagocytic cells (e.g. by granulocyte/monocyte-colony stimulating 
factor or GM-CSF) or mediating other pro-inflammatory functions (e.g. IL-6, TNFα) 
(Eckmann and Kagnoff, 2001).  
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In addition to the epithelial cells, phagocytic cells such as macrophages and monocytes are 
critical components of the innate immune response to Salmonella Typhimurium (Wick, 2004). 
The key role of macrophages and monocytes is to control and clear Salmonella infection from 
the host and this is characterized by a delicate balance between the macrophage effector 
mechanisms to kill the pathogen and the bacterial defence to resist this killing. Exposure to 
Salmonella promotes monocytes and macrophages to produce a series of cytokines including 
pro-inflammatory cytokines (e.g. IL-1, TNFα, IL-6), chemokines (e.g. macrophage 
inflammatory protein, MIP) and hematopoietic growth and survival factors (e.g. GM-CSF) 
each of them playing a role in attracting phagocytic cells to the infection site and in inducing 
acute inflammatory events (Eckmann and Kagnoff, 2001).  
The host senses the presence of Salmonella Typhimurium in tissues by detecting PAMPs (e.g. 
LPS, flagellin) or patterns of pathogenesis (e.g. T3SS-1-dependent delivery of proteins) 
through PRRs which are located in the cell membrane, the cytosol or the humoral 
compartment.  
 
 
Figure 12: Schematic overview of the antibacterial inflammatory response as a result the detection of 
Salmonella Typhimurium (Thiennimitr et al., 2012). 
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As illustrated in Figure 12, signaling through these PRRs will result in the production of IL-
1β, IL-12, IL-18, IL-23, TNFα, IFNγ and C5a, initiating three important antibacterial 
responses in tissues: the epithelial release of antimicrobials, the recruitment of neutrophils and 
the activation of macrophages (reviewed by Eckman and Kagnoff, 2001; Santos et al., 2009; 
Thiennimithr et al., 2012).  
IFNγ plays a central role in controlling Salmonella infection by activating the ability of 
macrophages to kill intracellular Salmonella. The production of IFNγ is largely induced by 
IL-12 and IL-18. IL-23 contributes to the production of IL-22, a cytokine that stimulates 
epithelial cells to release antimicrobials into the intestinal lumen. In synergy with IL-1β, IL-
23 also induces the production of IL-17, the latter acting in concert with IL-1β and TNFα to 
induce the release of CXC chemokines from epithelial cells. Together with the complement 
factor C5a, these CXC chemokines play an important role in the recruitment of neutrophils to 
the intestinal lumen. 
 
 
4. Crosstalk between Salmonella and deoxynivalenol: potential mode of action? 
 
Exposure to ribotoxic stressors such as the trichothecene mycotoxin DON results in a 
coordinated signaling cascade linked to the activation of MAPKs. This not only leads to 
alterations of intestinal mucosal integrity but can also trigger intestinal and systemic 
inflammation (Moon, 2012).  
The pathogenesis of a Salmonella Typhimurium infection is characterized by a dynamic and 
complex interplay between the host and the bacterium (Haraga et al., 2008). Salmonella is 
able to subvert the host cell cytoskeleton, signal transduction pathways, membrane trafficking 
and pro-inflammatory responses by using its specialized effector proteins (McGhie et al., 
2009).  
A potential mode of action for the crosstalk between DON and Salmonella Typhimurium 
could be the MAPKs signal transduction cascade since this pathway is not only involved in 
actin dynamics and subsequent regulation of  the host cell cytoskeleton, but also plays a role 
in the induction of pro-inflammatory cytokines. 
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Worldwide, the contamination of cereal-based commodities by mycotoxins is an emerging 
issue with a considerable impact on human and animal health. In pig industry, the 
contamination of feed with deoxynivalenol (DON) is of great concern due to the high 
sensitivity of pigs to the toxic effects of this mycotoxin, and the high exposure level resulting 
from their cereal-rich diet. Most studies have focused on the effects of high concentrations of 
DON in pig feed. However, the impact of DON at low and in practice more relevant 
concentrations is poorly understood. 
Salmonella Typhimurium is one of the leading serotypes causing human non typhoid 
salmonellosis. Pork meat, derived from mostly asymptomatic Salmonella carrier pigs 
constitutes an important source of Salmonella Typhimurium infections for humans. The 
course of a Salmonella infection in pigs depends on numerous factors. However, whether 
highly prevalent mycotoxins in feed affect the course of an infection with Salmonella 
Typhimurium in pigs has not been studied. 
The intake of DON contaminated feed leads to a mucosal ribotoxic stress which specifically 
affects the highly dividing intestinal epithelial cells and the underlying mucosa-associated 
leucocytes. Considering the importance of these cells in the pathogenesis of Salmonella 
Typhimurium infections, co-exposure to DON may result in altered interactions between 
Salmonella Typhimurium and its porcine host. Therefore, the main goal of the present study 
was to investigate the effects of exposure to low concentrations of DON on the pathogenesis 
of a Salmonella Typhimurium infection in the pig. 
 
The specific objectives of this thesis were as follows:  
 To examine the effects of low and non-cytotoxic concentrations of DON on the 
intestinal phase of a Salmonella Typhimurium infection, using both an in vitro model 
of porcine intestinal epithelial cells and an ex vivo porcine ligated ileal loop model. 
 To investigate whether exposure to low and non-cytotoxic concentrations of DON 
could affect the interaction of Salmonella Typhimurium with the macrophage, using 
an in vitro model of primary porcine alveolar macrophages. 
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ABSTRACT 
 
Background and aims: Both deoxynivalenol (DON) and nontyphoidal salmonellosis are 
emerging threats with possible hazardous effects on both human and animal health. The 
objective of this study was to examine whether DON at low but relevant concentrations 
interacts with the intestinal inflammation induced by Salmonella Typhimurium. 
 
Methodology: By using a porcine intestinal ileal loop model, we investigated whether intake 
of low concentrations of DON interacts with the early intestinal inflammatory response 
induced by Salmonella Typhimurium.  
 
Results: A significant higher expression of IL-12 and TNFα and a clear potentiation of the 
expression of IL-1β, IL-8, MCP-1 and IL-6 was seen in loops co-exposed to 1 µg/mL of DON 
and Salmonella Typhimurium compared to loops exposed to Salmonella Typhimurium alone. 
This potentiation coincided with a significantly enhanced Salmonella invasion in and 
translocation over the intestinal epithelial IPEC-J2 cells, exposed to non-cytotoxic 
concentrations of DON for 24 h. Exposure of Salmonella Typhimurium to 0.250 µg/mL of 
DON affected the bacterial gene expression level of a limited number of genes, however none 
of these expression changes seemed to give an explanation for the increased invasion and 
translocation of Salmonella Typhimurium and the potentiated inflammatory response in 
combination with DON.  
 
Conclusion: These data imply that the intake of low and relevant concentrations of DON 
renders the intestinal epithelium more susceptible to Salmonella Typhimurium with a 
subsequent potentiation of the inflammatory response in the gut. 
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INTRODUCTION 
 
The contamination of food and feed with mycotoxins poses a worldwide problem with an 
acknowledged negative effect on both human and animal health and significant economic and 
international trade implications. Deoxynivalenol (DON) is a trichothecene mycotoxin 
frequently contaminating maize and small grain cereals in temperate regions of Europe, North 
America and Asia (Bottalico and Perrone, 2002). The intake of DON contaminated food or 
feed can lead to adverse health effects in both humans and animals. For humans, a large-scale 
European study on the occurrence of Fusarium toxins and the dietary intake showed that 57% 
of the tested cereals samples such as wheat were positive for DON and based on the intake 
estimates, it is clear that the presence of trichothecenes can pose a public health concern 
(Schothorst and van Egmond, 2004; Gonzalez-Osnaya et al., 2011). A study on the prevalence 
and level of urinary DON in the United Kingdom population indicated that urinary levels of 
DON were positively correlated with cereal intake suggesting that the European Union 
recommended maximum tolerable daily intake of 1 µg DON/kg BW may be exceeded. 
Urinary DON levels can be a valuable tool as exposure biomarker for biomonitoring in 
etiological studies of DON and human disease risks (Turner et al., 2008). For human food 
products, the European Union sets maximum limits for DON in cereals and cereal-based 
products, ranging from 200 to 1750 µg/kg (European Commission, 2007). Anorexia, altered 
feed intake, reduced weight gain and immunologic alterations are associated with chronic 
low-doses ingestion of DON whereas acute high-dose exposure is characterized by emesis, 
diarrhea, vomiting and rectal bleeding. Among farm animals, pigs are considered particularly 
sensitive to the dietary intake of DON resulting in substantial economical losses (Böhm, 
1992). 
Nontyphoidal Salmonella represents an important human and animal pathogen worldwide. 
Each year approximate 93.8 million human cases of gastroenteritis occur due to Salmonella 
Typhimurium around the world (Majowicz et al., 2010). In 2009, Salmonella was the most 
commonly reported bacteriological agent of human food borne diseases in the USA, causing 
approximate 44% of confirmed food borne bacterial infections (Prevention CfDCA, 2009). 
Salmonella Typhimurium is, together with Salmonella Enteriditis, the most common serotype 
associated with human nontyphoidal salmonellosis in Europe and USA (Eurosurveillance 
website, 2011; Doyle et al., 2009). In pigs, clinical salmonellosis is not a common problem as 
Salmonella infections are mostly subclinical. However, these carrier pigs are an important 
contaminating source for the environment, other pigs and carcasses in the slaughterhouse and 
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as such they pose a serious public health problem being the most important reservoir of 
Salmonella Typhimurium for humans (Wray, 2000; Donné et al., 2005; Boyen et al., 2008).  
Several studies already described the direct effects of the intake of DON contaminated food or 
feed on the gastrointestinal tract (Kasuga et al., 1998; Maresca et al., 2002; Sergent et al., 
2006; Obremski et al., 2008; Kolf-Clauw et al., 2009; Pinton et al., 2009, 2010; Danicke et 
al., 2010; Van De Walle et al., 2010b; Diesing et al., 2011), however only few examined the 
possible link between DON ingestion and intestinal inflammation using in vitro intestinal 
cells line models (Bouhet and Oswald, 2005; Mbandi and Pestka, 2006; Maresca et al., 2008; 
Van De Walle et al., 2008, 2010a; Maresca and Fantini, 2010). The general effects of 
mycotoxins on the local intestinal immune response were reviewed by Bouhet and Oswald 
(2005), whereas Mbandi and Pestka (2006) examined the capacity of DON to potentiate 
chemokine and pro-inflammatory cytokine production in murine macrophages induced by 
killed irradiated suspensions of Salmonella Typhimurium, concluding that the induction of 
IL-1β, IL-6, TNFα and MIP-2 by the pathogen was potentiated by DON. Maresca et al. 
(2008) indicated that besides the direct pro-inflammatory effect and potentiation of an 
existing inflammation, DON could also cause intestinal inflammation indirectly through 
alteration of the intestinal barrier function. Van De Walle et al. (2008, 2010a) suggested that 
high concentrations of DON could trigger intestinal inflammation and worsen inflammation 
related parameters.  
Recently a potential link between food-associated exposure to certain mycotoxins including 
DON, and the induction and/or persistence of Inflammatory Bowel Disease (IBD) in 
genetically predisposed patients has been suggested (Maresca and Fantini, 2010). At realistic 
doses, mycotoxins are able to cause immune and intestinal alterations comparable with those 
involved in human chronic intestinal inflammatory diseases (Bouhet and Oswald, 2005). In 
addition, infections with enteric pathogens such as nontyphoidal Salmonella have been 
implicated in the etiology of IBD (Gradel et al., 2009; Jess et al., 2011).  
With DON and salmonellosis being emerging issues with possible deleterious consequences 
for both animal and human health, and with the gastrointestinal tract being the primary target 
for both, we aimed to test whether DON at low but relevant concentrations interacts with the 
intestinal inflammation induced by Salmonella Typhimurium using a porcine model of 
infection, as representative of the human gastrointestinal gut (Almond, 1996; Rothkotter et 
al., 2002; Niewold et al., 2005).  
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MATERIALS AND METHODS 
 
Ethics statement 
The in vivo experimental protocols and care of the animals were approved by the Ethical 
Committee of the Faculty of Veterinary Medicine, Ghent University, Belgium (EC 2010/065, 
May 3, 2010).  
 
Chemicals 
DON stock solution of 1 mg/mL (Sigma-Aldrich, Steinheim, Germany) was prepared in 
anhydrous methanol and stored at -20 °C. Serial dilutions of DON were prepared in cell 
medium or Luria-Broth (LB, Sigma-Aldrich), depending on the experiment. 
 
Bacterial strains and growth conditions 
Salmonella enterica subspecies enterica serovar Typhimurium (Salmonella Typhimurium) 
strain 112910a was used as wild type strain. To obtain highly invasive late logarithmic 
cultures for invasion assays, 2 µL of a stationary phase culture was inoculated in 5 mL LB 
and grown for 5 h at 37 °C without aeration.  
The inocula for the intestinal loop model were prepared according to the temperature shift 
method for Salmonella. Cultures in LB were shaken at 130 rpm for 24 h at 25 °C. After 
diluting threefold and adjusting the OD600nm to 1, the bacteria were incubated for 2 h at  37 °C, 
with shaking at 130 rpm. The actual number of bacteria/mL was assessed by plating tenfold 
dilutions on Brilliant Green agar (BGA, Oxoid, Hampshire, UK). 
 
Cell cultures 
The IPEC-J2 cell line, a non-transformed intestinal cell line, which was originally derived 
from jejunal epithelium of an unsuckled piglet was used for all the experiments (Roads et al., 
1994; Schierack et al., 2006). IPEC-J2 cells were cultured in Dulbecco’s Modified Eagle 
Medium (DMEM)/Ham’s F-12 (1:1) (InvitrogenTM Life Technologies, Carlsbad, CA, USA) 
supplemented with 5% (v/v) FCS (Hyclone, Cramlington, England, UK), 1% (v/v) 
insulin/transferrin/Na-selenite (Gibco, Life Technologies, Paisley, Scotland), 1% (v/v) 
penicillin/streptomycin (Gibco) and 1% (v/v) kanamycin (Gibco).  
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Cytotoxicity assay 
IPEC-J2 cells were seeded into a 96-well plate at a concentration of 1 x 10
5
 cells/mL and 
cultured for 1 day or 21 days, representing undifferentiated proliferating and highly 
differentiated IPEC-J2 cells respectively, after which the cells were exposed to DON at a 
concentration of 0.01, 0.025, 0.05, 0.1, 0.25, 0.5, 1, 5 or 10 µg/mL during 24 h. The cells were 
maintained in an atmosphere of 5% CO2 at 37 °C. To assess cytotoxicity, 150 µL of freshly 
prepared neutral red solution (33 mg/L in DMEM without phenol red) prewarmed to 37 °C 
was added to each well and the plate was incubated at 37 °C for an additional 2 hours. The 
cells were then washed two times with Hanks Buffered Saline Solution (HBSS) and 150 µL 
of extracting solution (ethanol/Milli-Q water/acetic acid, 50/49/1 (v/v/v)) was added in each 
well. The plate was shaken for 10 min. The absorbance was determined at 540 nm using a 
microplate ELISA reader (Multiscan MS, Thermo Labsystems, Helsinki, Finland). The 
percentage of viable cells was calculated using the following formula: 
 
% viability = 100 x  
In this formula a = OD540nm derived from the wells incubated with DON, b = OD540nm derived 
from blank wells, c = OD540nm derived from untreated control wells. 
 
Invasion and translocation assays of Salmonella Typhimurium in porcine intestinal 
epithelial cells 
To examine whether the ability of Salmonella Typhimurium to invade in and translocate 
through a monolayer of IPEC-J2 cells was altered after pre-exposure of the IPEC-J2 cells to 
DON, invasion and translocation assays were performed. 
For the invasion assays, IPEC-J2 cells were seeded in 24-well plates at a density of 1 x 10
5
 
cells per well and were cultured for 1 day or 21 days depending on the experimental setup. 
The 1-day-old cells were then exposed either to non-cytotoxic concentrations of DON up to 
0.1 µg/mL, and to 0.25 µg/mL which decreased the percentage of viable cells to 62.3% as 
determined by the cytotoxicity assay described above. The 21-days-old IPEC-J2 cells were 
exposed to non-cytotoxic concentrations of DON up to 1 µg/mL. The invasion assay was 
performed as described by Boyen et al. (2009). To quantify the transepithelial passage of 
Salmonella Typhimurium through IPEC-J2 cells exposed to DON, IPEC-J2 cells were seeded 
on Transwell
® 
inserts with a pore size of 3.0 µm and membrane diameter of 6.5 mm (Corning 
Costar Corp., Cambridge, MA) at a density of 5 x 10
5
 cells/mL and cultured until 21 days 
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after reaching confluence. Cell medium was refreshed every 3 days. DON was added at 
concentrations of 0.1, 0.25, 0.5, 0.75 or 1 µg/mL to the apical side in 200 µL of culture 
medium. The basolateral side received 1 mL of blank culture medium. After 24 h of treatment 
with DON, the Transwell
®
 inserts were washed three times with HBSS. Then Salmonella 
Typhimurium was added to the apical compartment at a concentration of 2 x 10
7
 colony 
forming units (CFU) per mL suspended in IPEC-J2 medium with the respective 
concentrations of DON but without supplementation of antibiotics. The basolateral 
compartment was filled with antibiotic-free IPEC-J2 medium. After 60 min at 37 °C and 5% 
CO2, the number of bacteria (CFU/mL) was determined in the basolateral compartment by 
plating tenfold dilutions on BGA plates. Transepithelial electrical resistance (TEER) 
measurements were performed before and after the incubation with DON in order to evaluate 
the cell barrier integrity. 
 
Porcine intestinal ileal loop experiments 
Considering the fact that the gastrointestinal tract and the immune system of pigs are very 
similar to that of humans (Almond, 1996; Rothkotter et al., 2002; Niewold et al., 2005), 
porcine intestinal loops were used to reproduce Salmonella Typhimurium induced intestinal 
inflammation.  
Two 5-week-old pigs were used in the gut loop experiments. Feed was deprived for 16 h 
before surgery. The pigs were anesthetized with a mixture of tiletamine+zolazepam (Zoletil 
100, Virbac, Carros, France) and xylazine (Xyl-M 2%, VMD, Arendonk, Belgium), given 
intramuscularly at 0.2 mL/kg bodyweight after which they were intubated intratracheally.  
Anesthesia was maintained with 1-3% isoflurane in conjunction with 1% pure oxygen using a 
semiclosed circuit. Intramuscular injection of fentanyl (5 µg/kg BW/h) was used for pain 
management. The porcine ligated loop model was performed as described before with slight 
modifications (Boyen et al., 2009). After cleaning and disinfection of the abdomen, a ventral 
line laparotomy was performed aseptically and twelve loops were produced commencing at 
the distal ileum, each 6 cm in length with a short intervening segment in between. Ligation 
was done by an intestinal circumferential ligature through the mesentery without damaging 
grossly visible mesenteric arcades and thus maintaining full blood supply for both loops and 
inter-loop segments.  
A volume of 1 mL of each test condition was injected into each loop. In each pig, the 
treatments were randomly assigned and performed in triplicate. Following test conditions 
were included: negative control (LB), 1 µg/mL of DON in LB, 4 x 10
8
 CFU/mL of 
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Salmonella Typhimurium and 1 µg/mL of DON in combination with 4 x 10
8
 CFU/mL of 
Salmonella Typhimurium. Piglets were maintained under anesthesia for 6 h after which they 
were euthanized using T61 intravenously (0.3 mL/kg bodyweight) (Intervet, Ukkel, Belgium) 
while still anesthetized. The pieces of the ligated intestine were then quickly excised from 
each loop and processed for RNA isolation. 
 
Analysis of intestinal cytokine response  
For RNA extraction, pieces of tissue samples were collected from the ileal loops, immediately 
frozen in liquid nitrogen and stored at -70 °C until analysis. Total RNA from the intestinal 
samples was isolated using RNAzol
®
RT (MRC Inc., Cincinnati, USA) according to the 
manufacturer’s instructions. The RNA concentration was measured by absorbance at 260 nm 
using Nanodrop spectrophotometer (Thermo Scientific, Wilmington, USA) and the purity of 
the RNA samples was checked using an Experion RNA StdSens Analysis kit (Biorad 
Laboratories, Hercules, CA, USA). 
Reverse transcription was carried out using the iScript cDNA Synthesis Kit (Biorad 
Laboratories). Briefly, reverse transcription was carried out in a 20 µL final volume that 
included 4 µL of 5x iScript Reaction Mix, 1 µL of iScript Reverse Transcriptase, 1 µL of 
RNA template (1 µg), and nuclease-free water to complete the final volume. The reverse 
transcription mix was incubated at 25 °C for 5 min, heated to 42 °C for 30 min, and 
inactivated at 85 °C for 5 min. The resultant cDNA was stored (-20 °C) until further use.  
Primers used for the amplification were designed using Primer3 software (available at 
http://frodo.wi.mit.edu/primer3) using the GeneBank sequences (Rozen and Skaletsky, 2000). 
The primers for IL-8, TNFα and IL-12 were adopted from Volf et al. (2007, 2010). The 
specificity of the primers was tested by performing a BLAST search against the genomic 
NCBI database. To optimize the amplification procedure, all primer pairs were designed to be 
used at the same annealing temperature (60 °C). The list of genes and sequences of the 
primers used for quantitative PCR analysis are listed in Table 1. HPRT and HIS were used as 
housekeeping genes. Both genes had a stable expression, for all the samples and test 
conditions tested, as calculated using the geNorm software (data not shown).  
To quantify the products of interest (IL-1β, IL-6, IL-8, IL-12, IL-18, TNFα, IFNγ and MCP-1) 
real-time quantitative PCR was utilized. The PCR reaction was carried out in 96-well plates 
with the appropriate forward and reverse primers (500nM), 5 µL of iQ
TM
 SYBR
®
Green 
Supermix (Biorad) and 1 µL of the fivefold diluted cDNA template. Thermocycling 
parameters were used according to the manufacturer’s instructions and included 40 cycles of 
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20 s at 95 °C, 30 s at 60 °C, 30 s at 73 °C. The threshold cycle values (Ct) were first 
normalized to the geometric means of appropriate reference mRNAs and the normalized 
mRNA levels were calculated according to 2
-ΔΔCt 
method (Livak and Schmittgen, 2001).
  
 
Table 1. List of genes and sequences of the primers used for quantitative PCR analysis.  
Gene 
name 
Forward primer (5’→3’) Reverse primer (3’→5’) Accession number 
HPRT GAGCTACTGTAATGACCAG
TCAACG 
CCAGTGTCAATTATATCTTCAACAA
TCAA 
NM_001032376 
HIS AAACAGATCTGCGCTTCC GTCTTCAAAAAGGCCAAC NM_213930 
IL-1β GGGACTTGAAGAGAGAAG
TGG 
CTTTCCCTTGATCCCTAAGGT NM_001005149 
IL-6 CACCGGTCTTGTGGAGTTT
C 
GTGGTGGCTTTGTCTGGATT M86722 
IL-8 TTCTGCAGCTCTCTGTGAG
GC 
GGTGGAAAGGTGTGGAATGC M86923 
IL-12 CACTCCTGCTGCTTCACAA
A 
CGTCCGGAGTAATTCTTTGC U08317 
IL-18 ATGCCTGATTCTGACTGTT
C 
CTGCACAGAGATGGTTACTGC AB010003 
TNFα CCCCCAGAAGGAAGAGTTT
C 
CGGGCTTATCTGAGGTTTGA NM_214022 
IFNγ CCATTCAAAGGAGCATGGA
T 
GAGTTCACTGATGGCTTTGC AY188090 
MCP-1 CAGAAGAGTCACCAGCAG
CA 
TCCAGGTGGCTTATGGAGTC NM_214214 
 
Micro-array analysis of Salmonella Typhimurium gene expression 
To test whether DON affected the gene expression of Salmonella Typhimurium, a microarray 
analysis was performed on RNA isolated from cultures of Salmonella Typhimurium grown to 
logarithmic and stationary phase in the presence or absence of 0.250 µg/mL of DON. This 
concentration was chosen based on the results of the in vitro assays on IPEC-J2 cells. 
Stationary phase cultures were obtained by aerated, overnight culture at 37 °C in 5 mL LB in 
50 mL flasks. To obtain highly invasive late logarithmic culture, 2 µL of a stationary phase 
culture was inoculated in 5 mL LB and grown for 5 hours at 37 °C without aeration 
(Lundberg et al., 1999). 
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Of the stationary and logarithmic culture respectively, 2.00 OD600 units were harvested and 
RNA was extracted and purified using SV Total RNA Isolation Kit (Promega Benelux bv, 
Leiden, The Netherlands) according to manufacturers’ instructions. The quality and purity of 
the isolated RNA was determined using a Nanodrop spectrophotometer and Experion RNA 
StdSens Analysis kit (Biorad). The SALSA microarrays and protocols for RNA labeling, 
microarray hybridization and subsequent data acquisition have been described previously 
(Nagy et al., 2006). RNA (10 µg) from 3 independent biological replicates of DON treated 
and untreated (control) logarithmic and stationary phase cultures was labeled with Cy5 dCTP 
and hybridized to SALSA microarrays with 400 ng of Cy3 dCTP labeled gDNA, as a 
common reference. Genes were assessed to be statistically significantly differently expressed 
between the DON treated and untreated controls at each growth phase by an analysis of 
variance test with a Benjamini and Hochberg false discovery rate of 0.05 and with a ≥ 1.5-
fold change in the expression level.  
 
Micro array accession number 
The microarray data discussed in this publication are MIAME compliant and have been 
deposited in NCBI's Gene Expression Omnibus (Edgar et al., 2002) and are accessible 
through GEO Series accession number GSE29399  
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29399) 
 
Statistical analysis  
All in vitro experiments were conducted in triplicate with three repeats per experiment, unless 
otherwise noted. The data were analyzed using Student’s t-test to address the significance of 
difference between mean values with significance set at 0.05.  
The differences in mRNA expression among groups were assessed by performing two-factor 
ANOVA after determination of normality and variance homogeneity. Multiple comparisons 
were performed using LSD post-hoc test. Not normally distributed data were analyzed using 
the non parametric Kruskal-Wallis analysis, followed by Mann-Whitney test using SPSS 17.0 
Software (SPSS Inc., Chicago, IL, USA). Significance level was set at 0.05.  
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RESULTS 
 
DON is more toxic to undifferentiated than to differentiated IPEC-J2 cells 
The cytotoxic effect of DON on IPEC-J2 cells as determined using the neutral red assay is 
shown in Figure 1. The viability of 1-day-old IPEC-J2 cells was significantly decreased by 
exposure to concentrations of DON higher than 0.1 µg/mL (Figure 1A). DON concentrations 
up to 10 µg/mL did not significantly affect the viability of differentiated IPEC-J2 cells (Figure 
1B). However, although not significant, exposure of differentiated IPEC-J2 cells to 5 and 10 
µg/mL of DON during 24 h reduced the viability to 86 +/- 7% and 80 +/- 4% respectively.  
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Figure 1: Percentage viability (%) of IPEC-J2 cells exposed to different concentrations of DON                   
(0.005 – 10 µg/mL). IPEC-J2 cells were grown to a confluent monolayer during 1 day (A) or grown until 
differentiation during 21 days (B). Twenty-four hours after incubation with DON, the cytotoxic effect was 
determined using neutral red assay. Results represent the means of 3 independent experiments conducted in 
triplicate and their standard error of the mean. * refers to a significantly higher cytotoxic effect compared to the 
unexposed control cells (p < 0.05).  
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DON promotes the invasion of Salmonella Typhimurium in IPEC-J2 cells  
The invasion of Salmonella Typhimurium was higher in undifferentiated proliferating IPEC-
J2 cells exposed to concentrations of DON higher than 0.025 µg/mL in comparison to non 
treated IPEC-J2 cells, with a significant increased invasion when exposed to 0.1 and 0.25 
µg/mL of DON during 24 h (p < 0.05), although the latter (0.25 µg/mL) reduced the 
percentage of viable IPEC-J2 cells to 62.3% (Figure 2A). The same tendency was seen in 
highly differentiated 21-days-old IPEC-J2 cells, where exposure to non-cytotoxic 
concentrations of DON led to a dose-dependent increase in the invasion of Salmonella 
Typhimurium in the cells. Exposure to concentrations of DON ≥ 0.75 µg/mL resulted in a 
significantly higher bacterial count in IPEC-J2 cells when compared to non treated control 
cells (Figure 2B). 
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Figure 2: The invasiveness of Salmonella Typhimurium in IPEC-J2 cells after exposure to different 
concentrations of DON. The number of invaded bacteria in actively dividing 1-day-old (A) or differentiated 21-
days-old (B) IPEC-J2 cells exposed to different concentrations of DON is shown. The 1-day-old cells were 
exposed either to non-cytotoxic concentrations of DON up to 0.1 µg/mL, and to 0.25 µg/mL of DON. The 21-
days-old IPEC-J2 cells were exposed to non-cytotoxic concentrations of DON up to 1 µg/mL. The results show a 
representative of three independent experiments conducted in triplicate + standard deviation. * refers to a 
significantly higher invasiveness compared to unexposed control cells (p < 0.05).  
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DON increases the transepithelial passage of Salmonella Typhimurium through the 
intestinal epithelium 
We assessed the passage of Salmonella Typhimurium through 21-days-old IPEC-J2 cells 
treated for 24 h with non-cytotoxic concentrations of DON varying from 0.1 to 1 µg/mL 
(Figure 3). Exposure to DON for 24 h did not lead to a decrease in TEER (data not shown) 
indicating no loss of integrity of the epithelial monolayer. However, there was a significant 
increase in the passage of Salmonella Typhimurium bacteria (p < 0.05) after exposure to 0.5, 
0.75 and 1 µg/mL of DON in comparison to non treated IPEC-J2 cells.  
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Figure 3: Impact of DON on transepithelial passage of Salmonella Typhimurium. IPEC-J2 cells seeded onto 
inserts until differentiation were either exposed to blank medium or treated with different concentrations of DON 
(0.1; 0.25, 0.5; 0.75 or 1 µg/mL) for 24 h, prior to measuring the transepithelial passage of Salmonella 
Typhimurium. The results show the means of four independent experiments conducted in triplicate with their 
standard error of the mean. * refers to a significantly higher translocation of the bacteria compared to the 
unexposed control cells (p < 0.05).  
 
DON potentiates the intestinal inflammatory response to Salmonella Typhimurium in 
the porcine intestinal ileal loop model 
Using the porcine intestinal loop model, the effect of 1 µg/mL of DON, Salmonella 
Typhimurium and co-exposure of Salmonella Typhimurium with 1 µg/mL of DON on the 
intestinal mRNA expression levels of the cytokines (IL-1β, IL-6, IL-12, IL-18, IFNγ and 
TNFα) and chemokines (IL-8 and MCP-1) 6 hours post administration was examined. The 
results are illustrated in Figure 4. Exposure to 1 µg/mL of DON did not significantly affect 
the mRNA expression level of any cytokine and chemokine tested. Co-exposure of the ileal 
loops to 1 µg/mL of DON and Salmonella Typhimurium for 6 hours, resulted in a potentiated 
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intestinal immune response in comparison to loops incubated with Salmonella Typhimurium 
but without the presence of DON. Although not significant, except for TNFα and IL-12        
(p < 0.05), there was a higher increase in fold change in mRNA expression compared to the 
Salmonella Typhimurium inoculated loops for IL-1β (10.9 to 6.1 respectively), IL-12 (6.5 to 
2.3 respectively), IL-8 (6.2 to 3.0 respectively), MCP-1 (2.5 to 1.2 respectively), TNFα (1.8 to 
0.9 respectively) and IL-6 (1.6 to 1.1 respectively). However, no increase in mRNA 
expression level was seen for IL-18 and IFNγ.  
 
Gene expression of Salmonella Typhimurium is affected by exposure to 0.250 µg/mL of 
DON 
In the stationary phase cultures of Salmonella Typhimurium, exposure to 0.250 µg/mL of 
DON did not affect the gene expression level of any gene tested in the microarray analysis.  
In the logarithmic culture, 159 genes were significantly (p < 0.05) up-or downregulated           
≥ 1.5-fold by exposure to 0.250 µg/mL of DON (Table 2). A general reduction in expression 
of genes involved in energy production as well as an increased expression of emrAB 
multidrug efflux systems was seen. Six genes known to play a role in the pathogenesis of a 
Salmonella infection were affected by exposure to 0.250 µg/mL of DON. Three Salmonella 
Pathogenicity Island-3 (SPI-3) genes were either upregulated (marT and fidL) or 
downregulated (cigR), as well as the gene encoding for the SipA protein and fliD and flgL, 
two genes encoding for hook-associate proteins, which were downregulated.  
 
 
 
 
 
 
 
 
 
 
Experimental studies: Chapter 1 
 
83 
 
0
2
4
6
8
10
12
14
1 µg/mL 
DON
ST 1 µg/mL 
DON + ST
IL-1β
b
b
0
1
2
1 µg/mL 
DON
ST 1 µg/mL 
DON + ST
IL-6
a
b
a,b
0
2
4
6
8
10
1 µg/mL 
DON
ST 1 µg/mL 
DON + ST
IL-8
a
b
b
0
1
2
3
1 µg/mL 
DON
ST 1 µg/mL 
DON + ST
IFNγ
b b
a
0
2
4
6
8
1 µg/mL 
DON
ST 1 µg/mL 
DON + ST
IL-12
c
b
0
1
2
3
1 µg/mL 
DON
ST 1 µg/mL 
DON + ST
IL-18
0
1
2
3
1 µg/mL 
DON
ST 1 µg/mL 
DON + ST
TNFα
a
b
a
0
1
2
3
4
1 µg/mL 
DON
ST 1 µg/mL 
DON + ST
MCP-1
a
b
a,b
a
a
F
o
ld
c
h
a
n
g
e
r
e
la
ti
v
e
to
 c
o
n
tr
o
l
lo
o
p
s 
a
 
 
Figure 4: Fold change in cytokine gene expression level of the porcine ileum relative to control loops. Ileal loops were exposed to 1 µg/mL DON, Salmonella Typhimurium 
or 1 µg/mL DON + Salmonella Typhimurium respectively. The intestinal mRNA expression levels of the cytokines (IL-1β, IL-6, IL-12, IL-18, IFNγ and TNFα) and 
chemokines (IL-8 and MCP-1) 6 hours post administration was examined. Data represent the normalized target gene amount relative to control which is considered 1. Data 
were presented as means + standard error of the mean for a total of 6 loops per test condition. Bars marked with different letters indicate significantly different responses (p < 
0.05). 
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Table 2. Results of the micro-array analysis of the logarithmic phase culture of Salmonella Typhimurium 
exposed to 0.250 µg/mL of deoxynivalenol. The genes in red are upregulated, the genes in blue are 
downregulated. 
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DISCUSSION 
 
Both DON and salmonellosis are worldwide emerging issues posing a threat for both animal 
and human health. To the best of our knowledge this is the first time that the combined effect 
of DON and an enteropathogenic pathogen such as Salmonella Typhimurium in vivo is 
demonstrated. 
A porcine gut loop model was used to determine whether co-exposure to a physiologically 
relevant concentration of DON could potentiate the early intestinal immune response induced 
by Salmonella Typhimurium infection in the intestine. The choice for administering 1 µg/mL 
of DON was based mainly on the Commission Recommendation 2006/576/EC setting down 
0.9 µg/g of DON in complementary and complete feeding stuff for pigs as guidance value 
(European Commission, 2006). Also, DON concentrations in human intestine are estimated 
between 0.160 µg/mL and 2 µg/mL depending on the contamination level of the food 
(Sergent et al., 2006). Moreover, 1 µg/mL was found non-cytotoxic to differentiated IPEC-J2 
cells. Undifferentiated proliferating IPEC-J2 cells are more susceptible to the toxic effects of 
DON compared to highly differentiated cells, as shown by the cytotoxicity assay. These 
results correspond with the literature describing DON to be less cytotoxic for differentiated 
Caco-2 cells compared to dividing cells. No cytotoxicity was observed after 24 h exposure in 
differentiated cells whereas inhibitory concentrations of 10% (IC10) value in the range         
0.9 – 1.2 µM (0.260 – 0.356 µg/mL) were measured for dividing cells (Bony et al., 2006).  
The results presented in this study provide evidence that DON at low but relevant intestinal 
concentrations enhances the intestinal inflammatory response to Salmonella Typhimurium. 
This is indicated by a significantly higher expression of IL-12 and TNFα  (p < 0.05) and a 
clear potentiation of the expression of IL-1β, IL-8, MCP-1 and IL-6 in loops co-exposed to 1 
µg/mL of DON and Salmonella Typhimurium. Whereas Maresca et al. (2008) described a 
dose-dependent increase in IL-8 mRNA levels in Caco-2 cells when exposed to 
concentrations of DON from 10 to 100 µM (≈ 3 - 30 µg/mL), exposure of the ileal loops to 1 
µg/mL of DON alone did not significantly affect the mRNA expression of any cytokine and 
chemokines tested. A possible explanation could be the lower dose of DON used in the ileal 
loop (1 µg/mL).  
The enhanced intestinal inflammation seen in the co-exposed loops may be due to a 
stimulation of Salmonella Typhimurium invasion in and translocation through the intestinal 
epithelium, as indicated by the results of the assays performed on both dividing and 
differentiated IPEC-J2 cells. It has indeed been suggested that bacterial invasion stimulates 
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the innate pathways of inflammation by recognition of the pathogen-associated molecular 
patterns of Salmonella Typhimurium by Toll-like receptors (TLRs) present on epithelial cells 
and monocytes resulting in the production of several cytokines such as IL-8 (Tukel et al., 
2006). 
Microarray analysis on the Salmonella Typhimurium gene expression revealed that exposure 
to DON only changed the gene expression in logarithmic phase culture of Salmonella 
Typhimurium and among these, only six genes of possible importance in the pathogenesis of a 
Salmonella infection were affected. The marT gene, a non essential gene for virulence, 
encodes for a regulatory protein and could be involved in other aspects of pathogenesis, such 
as chronic infection and host specificity. The fidl and cigR gene products do not exhibit 
sequence similarity to proteins with known functions in the sequence database (Blanco-Potard 
et al., 1999). The genes fliD and flgL encode for proteins involved in flagellar biosynthesis 
(Yokoseki et al., 1995) and the effector protein SipA has been shown to modulate actin 
dynamics in order to promote Salmonella entry into epithelial cells (Higashide et al., 2002). 
The general reduction in expression of genes involved in energy production indicates a 
possible toxic effect of DON on Salmonella. The increased expression of emrAB multidrug 
efflux systems suggests that these could be involved in the removal of DON out of the 
bacterium. No changes in gene expression were seen in the stationary phase culture of 
Salmonella Typhimurium exposed to DON, indicating that the Salmonella virulence was not 
enhanced by DON. Since none of these bacterial gene expression alterations seem to offer a 
clear explanation for the increased invasion and translocation of Salmonella Typhimurium 
and the subsequent potentiated inflammatory response seen after coexposure to DON, we can 
thus conclude that the action of DON is more likely to occur on the epithelial cells than on 
Salmonella. This enhanced intestinal inflammation may be of importance for patients 
genetically predisposed for IBD since both DON and Salmonella are mentioned as factors of 
potential etiological importance in the development of this chronic intestinal disorder (Gradel 
et al., 2009; Maresca and Fantini, 2010; Jess et al., 2011). 
The potency of non-cytotoxic concentrations of DON to enhance the susceptibility of porcine 
host cells and porcine macrophages in specific, to Salmonella invasion is also described in the 
experimental studies in chapter 2 (Vandenbroucke et al., 2009). 
In pigs, intake of DON contaminated feed might result in a higher infection level in the herd 
and consequently a higher public health risk for salmonellosis from the consumption of 
contaminated pork meat.  
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In conclusion, our results indicate that the intake of DON contaminated food or feed at 
realistic contamination levels and after short-term exposure, could render the intestinal 
epithelium more susceptible for invasive food pathogens such as Salmonella Typhimurium 
with a subsequent amplification of the inflammatory processes in the gut. Considering the 
frequent occurrence of DON in cereal-based foods and feeds worldwide, the importance of 
these findings should not be underestimated. 
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ABSTRACT 
 
Both the mycotoxin deoxynivalenol (DON) and Salmonella Typhimurium are major issues in 
swine production. This study aimed at examining the interaction between DON and 
Salmonella Typhimurium at the level of the porcine innate immune system, represented by 
macrophages. First, we assessed the direct cytotoxic effect of DON on porcine macrophages. 
Incubation with 0.25 µg/mL of DON or higher resulted in a significant cytotoxic effect after 
24 h of incubation. Secondly, the direct toxic effect of DON on the growth and on the 
expression of SPI-1 and SPI-2 virulence genes of Salmonella Typhimurium was determined. 
At low non-cytotoxic concentrations, as can be found in the serum of pigs, DON did not have 
any effect on either growth or virulence gene expression of Salmonella Typhimurium. 
However, when the invasion and intracellular survival of Salmonella Typhimurium in 
macrophages pre-exposed to 0.025 µg/mL of DON was examined, DON significantly 
promoted the uptake of Salmonella Typhimurium into macrophages. The enhanced uptake 
coincided with marked F-actin reorganization of the cells, which was due to the activation of 
extracellular signal-regulated protein kinase 1/2 (ERK1/2). These results suggest that low but 
relevant concentrations of DON modulate the innate immune system and could thus increase 
the susceptibility of pigs to infections with Salmonella Typhimurium. 
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INTRODUCTION 
 
In the northern temperate regions the mycotoxin deoxynivalenol (DON) is one of the most 
frequent contaminants of maize and small grain cereal (Bottalico and Perrone, 2002). This 
contamination of cereal crops in the field is seen under low temperature and high humidity 
conditions. If critical concentrations of DON in diets for farm animals are exceeded, the 
health, growth and reproductive performance of animals may be impaired (Döll and Dänicke, 
2004). The toxic effects of DON have been well documented and among farm animals, pigs 
seem to be particularly sensitive to the dietary intake of DON. DON has been associated with 
symptoms varying from partial feed refusal and decreased feed intake at feed concentrations 
as low as 1-2 mg/kg feed, to vomiting and complete feed refusal at concentrations of more 
than 20 mg/kg feed (Trenholm et al., 1988; Haschek et al., 2002). Substantial economic losses 
have therefore been attributed to DON contamination of pig feed (Böhm, 1992).  
 
The mechanism of toxicity for trichothecenes, to which DON belongs, is complex, but the 
biochemical basis is non-competitive inhibition of different steps in the protein synthesis by 
interfering with peptidyltransferase at the active site on ribosomes (Cole and Cox, 1981). 
However, many of their toxic effects might also be related to a rapidly ensuing dysregulation 
of intracellular cell signaling and consequent alterations in downstream gene expression 
(Pestka, 2008). Exposure to low levels of trichothecenes appears to promote expression of a 
diverse array of cytokines and pro-inflammatory genes in vitro and in vivo via a mechanism 
known as the ribotoxic stress response that involves multiple intracellular signaling cascades 
(Zhou et al., 2003, 2005; Pestka et al., 2004). Trichothecenes such as DON are also known to 
rapidly activate mitogen-activated protein kinases (MAPKs) via a process termed the 
‘ribotoxic stress response’. These MAPKs modulate numerous physiological processes 
including cell growth, differentiation and apoptosis and are crucial for the signal transduction 
in the immune response. The members of the MAPKs family can be classified into three 
subfamilies: extracellular signal-regulated kinase (ERK)/MAPK, p38 and c-Jun-N-terminal 
kinase (JNK). Yang et al. (2008) described that DON induces p21 mRNA stability in terms of 
interaction with RNA-binding proteins via ERK1/2 activation. P21-activated kinases (PAK) 
are known to modulate cell morphology, actin/microtubule dynamics and cell motility 
(Bokoch, 2003) whereas ERK is able to phosphorylate several target proteins in the cytoplasm 
including cytoskeletal proteins. In contrast to these stimulatory effects, high doses of 
trichothecenes promote rapid onset of leucocyte apoptosis and this will be manifested as 
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immunosuppression (Pestka et al., 2004).  
 
In European countries, Salmonella enterica subspecies enterica serovar Typhimurium 
(Salmonella Typhimurium) is the predominant serovar isolated from pigs, which most often 
carry the bacterium without obvious symptoms (Fedorka-Cray et al., 2000; Boyen et al., 
2008). These carrier pigs, however, play an important role as a source of contamination for 
the environment and for other animals and after slaughter, their carcasses can be a source of 
contamination for other carcasses in the slaughter facility (Donné et al., 2005). Macrophages 
play an important role in the pathogenesis of Salmonella infections in pigs as the bacteria are 
able to survive and even multiply intracellularly after bacterial entry into the cells. 
Macrophage invasion coincides with membrane ruffles, bacterium uptake and formation of 
Salmonella containing vacuoles (Finlay et al., 1991; Monack et al., 1996). Two major 
virulence determinants of Salmonella Typhimurium are the Salmonella pathogenicity island 
(SPI) 1 for invasion and SPI-2 for intracellular proliferation (Marcus et al., 2000; Boyen et 
al., 2008). Two major regulators for the SPI-1 or SPI-2 gene expression are respectively HilA 
and SsrA. 
 
Several studies describe an increased susceptibility to experimental or natural mucosal 
infections after the ingestion of some mycotoxins (Tai et al., 1988; Fukata et al., 1996; Stoev 
et al., 2000). Hara-Kudo et al. (1996) examined the effects of DON on Salmonella Enteritidis 
infection in mice and suggested that administration of 2 mg/L DON in the drinking water 
reduced resistance to peroral infection of Salmonella Enteritidis presumably by inhibiting the 
cell-mediated immune function. However, until now there are no data available describing a 
possible interaction between DON and the pathogenesis of a Salmonella Typhimurium 
infection in pigs. The aim of the present study was to examine the effect of DON on the 
interaction of Salmonella Typhimurium with porcine macrophages, at low DON levels that 
are not cytotoxic and do not impair Salmonella growth and virulence gene expression. 
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MATERIALS AND METHODS 
 
Chemicals 
DON, ERK1/2 inhibitor (U0126 ethanolate) (Favata et al., 1998), ERK1/2 activator phorbol 
myristate acetate (PMA) (Das et al., 2000) and dimethyl sulfoxide (DMSO) were purchased 
from Sigma-Aldrich (St. Louis, MO, USA). DON stock solution of 4 mg/mL was prepared in 
anhydrous methanol and stored at -20 °C. Serial dilutions of DON were, depending on the 
experiment, prepared in Luria-Broth (LB, Sigma-Aldrich, Steinheim, Germany) or in the 
corresponding cell medium allowing the addition of similar volume of vehicle in all 
experiments. Macrophages seeded onto 24-well or 96-well plates were treated with selected 
concentrations of DON or equivalent volumes of medium (untreated cells). The ERK1/2 
inhibitor U0126 ethanolate was dissolved in DMSO leading to a 3 mM stock solution and 
stored at -20 °C. For experiments, U0126 ethanolate was diluted in the corresponding cell 
medium to a final concentration of 10 µM. The PMA stock solution was prepared by 
dissolving 5 mg of PMA in 1 mL of ethanol and stored in small aliquots at -20 °C. Prior to 
use, the stock solution was further diluted in the corresponding cell medium to a final 
concentration of 50 ng/mL. 
 
Bacterial strains and growth conditions 
Salmonella enterica subspecies enterica serovar Typhimurium (Salmonella Typhimurium) 
strain 112910a was used as the wild type strain (WT) in which all mutant strains were 
constructed. To obtain highly invasive late logarithmic cultures for invasion assays (Lundberg 
et al., 1999), 2 µL of a stationary phase culture was inoculated in 5 mL LB and grown for 5 h 
at 37 °C without aeration. The construction and characterization of a deletion mutant in the 
gene encoding the SPI-1 translocator/effector protein SipB has been described before (Boyen 
et al., 2006). Salmonella Typhimurium strains carrying the plasmid containing either the hilA-
luxCDABE or the ssrA-luxCDABE transcriptional fusions were used in the virulence gene 
expression experiments (Boyen et al., 2006). For fluorescence microscopy, the pFPV25.1 
plasmid expressing green fluorescent protein under the constitutive promoter of rpsM was 
used (Valdivia and Falkow, 1996; van Immerseel et al., 2004; Boyen et al., 2008). 
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Isolation of porcine pulmonary alveolar macrophages 
Porcine pulmonary alveolar macrophages (PAM) were isolated by broncho-alveolar washes 
from lungs of euthanized 3 to 4 week old piglets, obtained from a Salmonella-negative farm, 
as described previously (Dom et al., 1992). The isolated cells were pooled and frozen in 
liquid nitrogen until further use. Prior to seeding the PAM, frozen aliquots of approximately 
10
7
 cells/mL, were thawed in phosphate-buffered saline (PBS) with 10% fetal calf serum 
(FKS, Hyclone, Cramlington, England) at 4 °C. Cells were washed 3 times in PBS and 
cultured in RPMI (Gibco, Life Technologies, Paisley, Scotland) containing 2 mM L-
glutamine (Gibco) and 1 mM sodium pyruvate (Gibco).  
 
Cytotoxicity assays 
The Cell Proliferation Reagent WST-1 kit from Roche Applied Science (Bazel, Switzerland) 
was used to assess the direct cytotoxic effect of DON on PAM. The test was used according 
to the manufacturer’s instructions. The absorbance of DON-treated wells was measured at 450 
nm using a microplate ELISA reader (Multiscan MS, Thermo Labsystems, Helsinki, Finland) 
and compared with a solvent-treated control. The percentages of DON induced cytotoxicity 
were calculated using the following formula: 
 
% cytotoxicity = 100 × 
)(
)()(
bc
babc


 
 
In this formula a = OD450 derived from the wells incubated with DON, b = OD450 derived 
from blank wells, c = OD450 derived from untreated control wells. 
In addition to the WST-1 assay, the lactate dehydrogenase cytotoxicity detection kit (LDH, 
Roche Applied Science) was used to measure cytotoxicity and cell lysis by detecting LDH 
activity released from damaged cells. The test was used in accordance to the manufacturer’s 
instructions and an ELISA plate reader at 492 nm was used to measure the absorbance.  
 
Effect of DON on the growth and on SPI-1 and SPI-2 virulence gene expression of 
Salmonella Typhimurium 
The effect of concentrations of DON from 0.005 to 50 µg/mL on Salmonella Typhimurium 
wild type was examined during 24 h in order to detect a direct toxic effect on the growth of 
the bacteria. Therefore, Salmonella Typhimurium was grown overnight in LB with aeration at 
37 °C after which a suspension of the bacteria (Mc Farland 0.5) was added to the different 
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concentrations of DON in a 96-well plate. The plate was incubated at 37 °C and after 24 h of 
incubation, the number of colony forming units (CFU) per mL was determined by titration. 
This step was carried out by making tenfold dilutions of 20 µL of the bacterial suspensions. 
Then six 20 µL samples of each dilution were inoculated on Brilliant Green agar (BGA) and 
incubated for 24 h at 37 °C after which the colonies were counted. 
A FluoroScan Ascent fluorometer (ThermoLabsystems) was used to quantify SPI-1 and SPI-2 
expression of Salmonella Typhimurium by measuring the light production (luminescence) of 
Salmonella Typhimurium strains carrying the plasmids containing either the hilA-lux CDABE 
or the ssrA-lux CDABE transcriptional fusions. Bacterial cultures were grown in microplates 
in 200 µL of LB medium supplemented with the different concentrations of DON and in non-
supplemented LB medium at 37 °C. Light production was measured every 15 min during 24 h 
and expressed as the relative gene expression. 
 
Invasion and intracellular survival assays 
To examine whether the ability of Salmonella Typhimurium and its isogenic sipB mutant to 
invade and proliferate in PAM was altered after pre-exposure of the macrophages to DON, 
invasion and intracellular survival assays were performed. Therefore, PAM were seeded in 
24-well plates at a density of approximately 5 × 10
5
 cells per well and were allowed to attach 
for at least 2 h. These wells were exposed to different non-cytotoxic concentrations of DON 
(0.005-0.100 µg/mL). After 24 h, the wells were rinsed and inoculated with Salmonella 
Typhimurium at a multiplicity of infection (moi) of 10:1. To synchronize the infection, the 
inoculated multiwell plates were centrifuged at 365 g for 10 min. After 30 min incubation at 
37 °C under 5% CO2, the wells were rinsed and fresh medium supplemented with 50 µg/mL 
gentamicin (Gibco) was added for 1 h. For the invasion assay the PAM were lysed with 1% 
(v/v) Triton-X (Sigma-Aldrich) for 10 min and 10-fold dilutions were plated out on BGA 
plates. To assess intracellular growth, the medium containing 50 µg/mL gentamicin was 
replaced after 1 h incubation with fresh medium supplemented with 10 µg/mL gentamicin and 
the number of viable bacteria was assessed 6 hours after infection as described above. All 
measurements were performed in triplicate and the experiment was carried out on 3 
independent occasions.  
To visualize the effect of DON on the number of cell-associated Salmonella bacteria, PAM 
were seeded in sterile Lab-tek
®
 chambered coverglasses (VWR, Leuven, Belgium) and 
exposed to 0.025 µg/mL of DON in cell medium or to cell medium only for 24 h at 37 °C. 
Subsequently the invasion and proliferation assay was performed as described before after 
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inoculation with green fluorescent protein (gfp)-producing Salmonella. Cells were washed 
three times to remove unbound bacteria. Cell trace
®
 calcein red-orange (Molecular Probes 
Europe, Leiden, The Netherlands) was added for 30 min at 37°C. Afterwards, cells were 
washed three times with PBS and fluorescence microscopy was carried out. In 100 
macrophages, the number of macrophages containing gfp-Salmonella was counted and the 
average number of cell associated bacteria was calculated. 
 
Morphological changes in macrophages 
Staining techniques were performed to visualize possible morphological changes in 
macrophages exposed to DON in order to explain the observed difference in uptake of 
Salmonella Typhimurium in macrophages whether or not exposed to DON.  
 
Haemacolor staining 
PAM were seeded onto 13-mm-circular glass slides (VWR) in a 24-well plate at a 
concentration of 1 × 10
6
 cells/mL and were incubated at 37 °C in 5% CO2 for at least 2 h. 
Subsequently, either 0.025 µg/mL of DON or cell medium was added. After incubation of 24 
h at 37 °C in 5% CO2, cells were washed three times with PBS containing Ca
2+ 
and Mg
2+
 
(PBS+) and stained with Haemacolor
®
 stain (Merck, Darmstadt, Germany). Glass slides were 
mounted with coverslips and observed microscopically in at least three time-independent 
assays. Attention was paid to cellular and nuclear changes with special focus on changes of 
the cell membrane, presence of membrane ruffles and apoptotic changes in the nucleus.  
 
Staining of F-actin with phalloidin-Texas Red X
®
 
PAM were seeded onto 13-mm-circular glass slides in a 24-well plate at a concentration of 
1 × 10
6
 per mL. After 2 h of incubation, the cells were exposed to cell medium, 0.025 µg/mL 
of DON, 10 µM of the ERK1/2 inhibitor U0126 ethanolate in combination with 0.025 µg/mL 
DON or 50 ng/mL of the ERK1/2 activator PMA for 24 h at 37 °C in 5% CO2. PAM exposed 
to cell medium served as negative control. Thereafter, they were gently washed twice with 0.5 
mL PBS+ at 37 °C, fixed with 0.5 mL 3.0% paraformaldehyde for 10 min at room 
temperature, gently washed again with 0.5 mL PBS+ and then permeabilized with 0.5 mL 
0.1% Triton X-100 in PBS+ for 2 min at room temperature. Following washing with PBS+, 
0.25 mL phalloidin-Texas Red X
®
 (Molecular Probes, Eugene, Oregon, USA) (1:100 in 
PBS+) was added to each well and the 24-well plate was incubated at 37 °C for 1 h. To 
remove unbound phalloidin, coverslips were gently washed twice with 0.5 mL PBS+ before 
Experimental studies: Chapter 2 
 
105 
 
visualization of the actin filaments with a fluorescence microscope (Leica Microsystem 
GmbH, Heidelberg, Germany). 
 
Apoptosis and necrosis staining 
A caspase-3 staining in combination with ethidium monoazide (EMA; Sigma-Aldrich) and 
counterstaining with Hoechst was performed to examine whether the observed cell 
morphology changes were associated with apoptosis or necrosis. Activation of caspases plays 
a central role in apoptosis with caspase-3 being one of the key effectors. EMA staining was 
used for the detection of nonviable cells, which can be either apoptotic or necrotic. The 
Hoechst staining, used as a nucleus staining technique, helped in the determination of cells as 
apoptotic or necrotic. Macrophages were described as apoptotic when the caspase-3 staining 
was positive and the EMA staining positive (late apoptosis) or negative (early apoptosis). 
Necrotic macrophages were negative for caspase-3 but positive for EMA. Normal living cells 
were negative for both caspase-3 and EMA. 
PAM were seeded in a 24-well plate at 1 × 10
6
 per mL and incubated at 37 °C in 5% CO2 to 
allow adhesion. After 2 h, 0.025 µg/mL of DON was added for 24 h. Cell medium served as 
negative control. Macrophages exposed to 3 µM of staurosporine for 3 h served as a positive 
control for apoptosis. For the staining protocol, cells were detached from the well through 
incubation with 0.3 mL trypsine for 10 min and pooled in a falcon tube together with the 
supernatant. After centrifugation (7 min, 365 g), the cells were resuspended in 0.5 mL of ice-
cold PBS. After another centrifugation step, the supernatant was prelevated and the pellet was 
resuspended in 0.5 mL of ice-cold EMA (1:20 in PBS). After an incubation step in the dark 
for 20 min, the falcon tubes were put under a light bulb during 10 min after which they were 
centrifuged (7 min, 365 g). After removal of the supernatant, the cells were fixed by 
resuspending the pellet in 0.5 mL paraformaldehyde 3% (w/v) in PBS for 10 min at room 
temperature. After a centrifugation (7 min, 365 g) and washing step with 0.5 mL PBS, the 
cells were permeabilized by incubating in 0.1 mL Triton-X 0.1% for 2 min followed by the 
addition of 0.9 mL PBS. From this point on, PBS was supplemented with 20% FCS to prevent 
the cells from sticking to the tube wall. Again, the cells were centrifuged followed by the 
addition of 0.1 mL of rabbit anti-active caspase-3 (Sigma-Aldrich) diluted 1:100 in PBS. 
After 1 h incubation at 37 °C, the cells were centrifuged, washed with PBS and afterwards 0.1 
mL of goat anti-rabbit FITC (1:50 in PBS) (Sigma-Aldrich) was added. The cells were 
incubated at 37 °C, protected from light, for 1 h. After centrifugation and washing in 0.5 mL 
PBS, the cells were counterstained with Hoechst (1 mg/mL, 1/100 dilution in PBS) for 15 min 
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protected from light. After a centrifugation step (7 min, 365 g) and a washing step with PBS, 
the remaining pellet was resuspended in 20-40 µL of PBS and 10 µL was mounted in a small 
drop of mounting medium (DABCO-glycerine). The cells were observed with a fluorescence 
microscope. 
 
Statistical Analysis 
All experiments were conducted in triplicate with three repeats per experiment, unless 
otherwise noted. The data were analyzed using ANOVA to address the significance of 
difference between mean values with significance level set at p < 0.05.  
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RESULTS 
 
Low DON concentrations do not affect macrophage viability 
The possible direct cytotoxic effect of DON on PAM at concentrations ranging from 0.005 to 
50 µg/mL as determined by the WST-1 assay is shown in Figure 1. DON had no significant 
effect at concentrations ≤ 0.100 µg/mL. At 0.250 µg/mL, DON had a significant cytotoxic 
effect of 85 ± 5% (p < 0.05) after 24 h of incubation. Concentrations of DON > 0.250 µg/mL 
showed a cytotoxicity of more than 97% (p < 0.05). The cytotoxicity determined by the LDH 
test was similar to the previous results (data not shown). Based on these results, only non 
cytotoxic concentrations of DON (< 0.250 µg/mL) were used in the further experiments. 
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Figure 1: Percentage cytotoxicity in porcine macrophages exposed to DON at 0.005 to 50 µg/mL. Twenty-four 
hours later, the cytotoxic effect was determined by WST-1 assay. Results represent the means of 3 independent 
experiments conducted in triplicate and their standard deviation. Superscript (a) refers to a significantly higher 
cytotoxic effect compared to the unexposed control wells (p < 0.05). 
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High concentrations of DON increase SPI-1 and SPI-2 expression of Salmonella 
Typhimurium  
Concentrations of DON from 0.005 to 50 µg/mL did not have any effect on the growth of 
Salmonella Typhimurium wild type (data not shown). 
 
High concentrations of DON (≥ 5 µg/mL) in LB medium significantly increased the 
expression of hilA and ssrA, which are regulators required for the expression of respectively 
the SPI-1 invasion genes or SPI-2 genes necessary for the intracellular replication and 
systemic infection of Salmonella Typhimurium (p < 0.05). The results are shown in Figure 2. 
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Figure 2: The expression of hilA and ssrA in Salmonella Typhimurium grown in LB medium supplemented with 
different concentrations of DON. The light production was measured every 15 min during 24 h and is expressed 
as the relative gene expression. The results represent the means of 3 independent experiments conducted in 
triplicate and their standard deviation. Superscript (a) refers to a significantly higher expression of hilA and ssrA 
compared to the unexposed control wells (p < 0.05). 
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DON promotes the uptake of Salmonella Typhimurium in porcine macrophages 
The results of the invasion and proliferation test of Salmonella Typhimurium WT in PAM 
with or without prior exposure to DON are summarized in Figure 3A. Uptake was higher in 
the PAM exposed to 0.025 µg/mL of DON compared to the PAM that were not exposed to 
DON (p < 0.05), with an average increase factor of 1.45. Similar results were obtained using 
the deletion mutant sipB (Fig. 3B). Intracellular replication, represented by log cfu/mL after 
proliferation minus log cfu/mL after invasion in porcine macrophages, of Salmonella 
Typhimurium WT in porcine macrophages whether or not exposed to 0.025 µg/mL of DON 
did not differ significantly (0.48 ± 0.339 versus 0.91 ± 0.529 respectively). 
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Figure 3: The invasiveness of Salmonella Typhimurium WT (A) and its isogenic ΔSipB (B) in porcine 
pulmonary macrophages whether or not exposed to 0.025 µg/mL of DON is shown. The number of gentamicin-
protected bacteria is shown. The results show a representative of three independent experiments conducted in 
sixfold ± standard deviation for Salmonella Typhimurium WT and of two independent experiments conducted in 
sixfold ± standard deviation for the deletion mutant in SipB. 
 
Experimental studies: Chapter 2 
 
110 
 
The enhanced uptake of Salmonella Typhimurium in PAM exposed to 0.025 µg/mL of DON 
was confirmed in an invasion and proliferation assay with gfp-Salmonella. The results of this 
experiment are summarized in Table I. Macrophages exposed to 0.025 µg/mL of DON were 
more frequently infected by Salmonella Typhimurium in comparison with the control PAM 
resulting in a higher bacterial count (average 3.9 versus 2.7 bacteria per macrophage, 
respectively) and a consequent higher number of bacteria in the PAM after 6 h. The 
proliferation rate of intracellular bacteria however, did not differ significantly between the 
control and the DON treated macrophages (2.8 versus 2.6 respectively).  
 
Table I. Results of the invasion and proliferation assay performed with gfp-producing Salmonella. The results 
show a representative of two independent experiments conducted in threefold. The number of cell associated 
bacteria was counted in 100 macrophages. The results represent the mean bacterial count per macrophages ± 
standard error of the mean (sem) after invasion (0 h) and after proliferation (6 h), as well as the proliferation rate.  
 
 Mean bacterial count ± sem Proliferation rate 
PAM 0 h 6 h  
control 2.7 ± 0.11 7.6 ± 0.35 2.8 
0.025 µg/mL DON 3.9 ± 0.13 10.1 ± 0.39 2.6 
 
 
DON causes morphological alterations and F-actin reorganization in porcine 
macrophages by activation of ERK1/2 
PAM were stained with Haemacolor after exposure to 0.025 µg/mL of DON for an incubation 
time of 24 h. This staining technique was used to test the hypothesis that DON alters the cell 
morphology and more specifically induces changes in the cell membranes which might result 
in an enhanced uptake of Salmonella Typhimurium WT. DON caused marked morphological 
alterations as the majority of the PAM showed ruffling of the cell (Fig. 4A-B). To examine 
the actin cytoskeleton, phalloidin was used as a specific probe for polymerized (F) actin. 
Macrophages exposed to 0.025 µg/mL of DON showed some marked morphological changes 
when compared with the non exposed controls. Macrophages incubated with 0.025 µg/mL of 
DON for 24 h demonstrated increased formation of ruffling membranes in 78.5 ± 2.26% of 
the macrophages in comparison with the control macrophages (10.3 ± 3.79%) (Fig. 4C-D).  
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In order to investigate whether the cytoskeletal rearrangements of macrophages after exposure 
to 0.025 µg/mL of DON, were due to the activation of the MAPK pathway, and more 
specifically ERK1/2, the actin staining experiment was repeated with on the one hand, DON 
in combination with the ERK1/2 inhibitor U0126 ethanolate, and on the other hand PMA, 
which is an ERK1/2 activator.  
 
Macrophages incubated with 10 µM U0126 ethanolate in combination with 0.025 µg/mL of 
DON, for 24 h, showed a normal F-actin distribution. Only 11.0 ± 2.00% of the macrophages 
demonstrated ruffling membranes. Macrophages incubated with 50 ng/mL of PMA for 24 h 
demonstrated increased formation of ruffling membranes in 97.3 ± 2.52% of the macrophages 
in comparison with the control macrophages (Fig. 4E-F) and macrophages treated with U0126 
ethanolate (data not shown). These results suggest that the increased membrane ruffling, 
caused by DON, is due to the activation of ERK1/2. 
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Figure 4: Porcine alveolar macrophages (PAM) whether or not exposed to 0.025 µg/mL of DON, stained with Haemacolor (A-B) or phalloidine-Texas Red
® 
staining 
technique (C-F). Figure A shows porcine macrophages not exposed to DON, whereas Figure B shows marked membrane ruffling in the DON exposed macrophages. Figures 
C to F show fluorescence microscopic pictures of actin filament arrangement in PAM either treated with cell medium (C), 0.025 µg/mL of DON (D), 10 µM of the ERK1/2 
inhibitor U0126 ethanolate in combination with 0.025 µg/mL of DON(E) or with 50 ng/mL of the ERK1/2 activator PMA (F), for 24 h. Control macrophages (C) and 
macrophages exposed to U0126 ethanolate in combination with DON (E) demonstrated a normal distribution of F-actin. DON (D) and PMA (F) exposed macrophages 
demonstrated increased formation of membrane ruffles (indicated by white arrows).  
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DON induced cell morphology changes are not associated with cellular apoptosis and 
necrosis 
To determine the cellular apoptosis and necrosis of PAM exposed to 0.025 µg/mL of DON 
during 24 h, the EMA, caspase-3 and Hoechst staining were examined in 100 macrophages on 
three independent occasions.  
No significant difference was seen between the PAM exposed to 0.025 µg/mL of DON and 
the control PAM which indicates that this concentration does not induce apoptosis nor 
necrosis. The results of this experiment are summarized in Table II. 
 
Table II. Results of the apoptosis and necrosis staining of porcine alveolar macrophages (PAM) whether or not 
exposed to 0.025 µg/mL of DON. The results represent the average percentage of cells showing apoptosis or 
necrosis and their standard deviation. Normal cells are negative for both EMA and caspase-3, necrotic cells are 
positive for EMA but negative for caspase-3, apoptotic cells are always positive for caspase-3 but can be EMA 
positive (late apoptosis) or negative (early apoptosis).  
 
 Average percentage (%) of cells ± sd 
PAM normal apoptosis necrosis 
control 80.7 ± 6.66 19.3 ± 6.66 0 ± 0 
0.025 µg/mL DON 76.3 ± 5.03 21.0 ± 5.00 2.7 ± 2.08 
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DISCUSSION 
 
DON and salmonellosis are emerging issues causing serious problems in the European pig 
industry. The toxic effects of the mycotoxin DON have been well documented in several 
animal species and in diverse cell culture experiments. Several publications indicate that the 
presence of this Fusarium mycotoxin in feed can seriously affect the health status of pigs and 
other animals (Rotter and Prelusky, 1996; Fink-Gremmels, 1999; Pinton et al., 2008). 
Salmonella Typhimurium is the predominant serovar isolated from pigs in Europe and since 
pigs may be subclinically infected, they are an important threat to both animal and human 
health. Although DON and Salmonella can be commonly encountered in the pig industry, this 
is the first report describing an interaction between DON and the pathogenesis of a 
Salmonella Typhimurium infection in pigs.  
 
Concentrations of DON higher than 0.1 µg/mL had a significant cytotoxic effect on porcine 
macrophages after 24 h of exposure. These results correspond with the literature where DON 
was described to inhibit the proliferation of Caco-2 cells in a dose dependent manner, with a 
significant effect appearing at 0.2 µg/mL (Sergent et al., 2006). Bimczok et al. (2007), 
however, described that DON only had a significant cytotoxic effect on monocyte-derived 
dendritic cells at 0.8 µg/mL. To eliminate a possible cytotoxic effect of DON on the porcine 
macrophages, we chose to work with concentrations of DON below 0.1 µg/mL in the further 
experiments. These low concentrations are relevant in practice since in several publications, 
depending on the dietary content of DON, serum concentrations of DON varying from 0.013 
to 0.026 µg/mL were measured in pigs (Dänicke et al., 2006; Goyarts et al., 2006).  
 
The growth of Salmonella Typhimurium was not affected by concentrations of DON up to 50 
µg/mL. Nevertheless, high concentrations of DON (≥ 5 µg/mL) in LB medium, significantly 
increased the expression of hilA and ssrA. Although this is an interesting observation, 
concentrations of 5 µg/mL of DON are exceptional contamination levels under field 
conditions and hence not relevant for the in vivo situation. 
 
Pre-exposure of macrophages to concentrations of DON as low as 0.025 µg/mL during 24 h, 
enhanced the susceptibility of macrophages for the uptake by Salmonella Typhimurium in the 
macrophages. On average, the colony forming units per mL were 150% higher compared to 
control macrophages. This was confirmed by microscopic evaluation using gfp-Salmonella. 
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Since 0.025 µg/mL of DON was proven not to affect the expression of SPI-1 and SPI-2 genes 
of Salmonella Typhimurium, the observed enhanced uptake might be caused by changes in 
the cell morphology. This hypothesis is also supported by the results of the invasion test with 
the ΔSipB strain which gave similar results as the wild type strain, indicating that the 
enhanced uptake seen after exposure of the PAM to DON, is not SPI-1 associated. 
 
Salmonella entry in host cells involves a complex series of actin cytoskeletal changes (Guiney 
and Lesnick, 2005). When we examined the cell morphology focusing on the cell membrane 
changes, we saw marked changes in DON treated porcine macrophages compared to non 
treated controls. Macrophages exposed to 0.025 µg/mL of DON demonstrated alterations of 
the cell membrane on Haemacolor staining. Special attention was paid on the ruffling of the 
cell membrane as this is a cytoskeletal change that is commonly described with the entry of 
Salmonella Typhimurium in the macrophages. Therefore, staining with phalloidin-Texas 
Red
®
, as specific probe for polymerized actin, was performed which clearly indicated a 
reorganization of F-actin and formation of membrane ruffles. 
 
ERK1/2, a MAPK, is activated both by trichothecenes such as DON via a process termed the 
‘ribotoxic stress response’ and by the invasion of Salmonella Typhimurium in macrophages 
(Procyk et al., 1999; Zhou et al., 2005). Recently, Yang et al. (2008) described that DON 
induces p21 mRNA stability in human epithelial cells in terms of interactions with RNA 
binding proteins via ERK 1/2 activation. Since the p21 activated kinases and the Rho-family 
of small GTP’ases play a central role in both actin dynamics, membrane ruffling and 
Salmonella induced invasion, p21 mRNA stabilization might explain the changes in the cell 
membrane morphology seen in macrophages exposed to 0.025 µg/mL of DON and might 
account for the enhanced uptake of Salmonella Typhimurium in porcine macrophages pre-
exposed to DON.  
 
To test the hypothesis that the modulations of the cytoskeleton in macrophages, caused by 
DON, are due to the activation of ERK1/2, staining with phalloidin-Texas Red
®
 was 
performed in macrophages after pre-exposure to an ERK1/2 activator (PMA) or an ERK1/2 
inhibitor (U0126 ethanolate) in combination with 0.025 µg/mL of DON. 
U0126 ethanolate inhibited the morphological rearrangements in macrophages that were 
exposed to DON, whereas PMA caused an increased formation of membrane ruffles. 
Moreover, PMA and DON treated macrophages have a similar morphology. These results 
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suggest that the increased membrane ruffling, caused by DON, is due to the activation of 
ERK1/2. 
 
In conclusion, we have shown that low concentrations of DON could modulate the 
cytoskeleton of macrophages through ERK1/2 F-actin reorganization resulting in an enhanced 
uptake of Salmonella Typhimurium in porcine macrophages.  
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The knowledge that consumption of mycotoxins can seriously affect human and animal health 
has led to an increasing public awareness on the implications of occurrence of mycotoxins in 
agricultural commodities. The production of mycotoxins by fungi is not only a climate-, plant- 
and storage-dependent problem (Paterson and Lima, 2010), also agricultural practices and use 
of fungicides can affect the mycotoxin contamination level of crops (Simon, 2004). The 
trichothecene deoxynivalenol (DON), which is mainly produced during the growth of 
Fusarium graminearum on cereals, is one of the most prevalent mycotoxins in temperate 
climate regions (McMullen et al., 1997). The ubiquitous distribution of DON, together with 
its resistance to processing, enables the toxin to persist in the human and animal food and feed 
supply. Whereas the clinical effects of acute exposure to high doses of DON are well 
documented, the consequences of chronic exposure to low subclinical doses are less specified. 
It is nevertheless true that the economic impact of decreased productivity, subtle but chronic 
damage to vital organs and tissues and increased disease incidence due to immune 
suppression is many times greater than that of acute livestock death (van Egmond and 
Speijers, 1994). Among farm animals, the pig is the most sensitive animal species to the toxic 
effects of DON. Being a highly sensitive food-producing animal of economic importance, the 
pig pre-eminently poses an animal model to study the impact of exposure to DON 
contaminated feed, not only for animal health but also for human health. Indeed, in addition to 
the mouse, the pig model has been proven to be a valuable tool for biomedical research due to 
its anatomic, physiologic and pathologic resemblance to human (Almond, 1996; Meurens et 
al., 2012).  
The molecular mode of action of DON lies in its ability to inhibit protein synthesis and to 
induce a ‘ribotoxic stress response’ characterized by the activation of mitogen-activated 
protein kinases (MAPKs) and their downstream targets (Shifrin and Anderson, 1999; Yang et 
al., 2000; Pestka, 2008). By this mechanism of toxicity, DON can affect numerous organs and 
tissues. The continuously proliferating and differentiating intestinal epithelial cells of the 
gastrointestinal tract, as well as the macrophages and innate immune system in general, 
appear extremely sensitive to the toxic effects of DON. Because of the important role of these 
two cell populations in the pathogenesis of a Salmonella Typhimurium infection in the pig, 
the main objective of this thesis was to investigate whether low concentrations of DON could 
affect the pathogenesis of a Salmonella Typhimurium infection in the pig, focusing on the 
interaction between Salmonella Typhimurium and the porcine host. Since DON and 
salmonellosis are two important issues in pig production, a possible interaction between these 
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two food-borne agents could have great repercussions not only for animal productivity but 
also from public health perspective. Although Salmonella infections in pigs are typically 
asymptomatic, carrier pigs can pose a reservoir of infection for humans.  
 
DON and Salmonella Typhimurium: working together at the intestinal level 
 
With the gastrointestinal tract being the first organ to be encountered after the intake of DON 
contaminated food or feed, the intestinal alterations caused by exposure to DON have been 
addressed in several studies. Of great concern however, is the observation that also low and 
per definition non-cytotoxic concentrations of DON seem to be able to affect this intestinal 
barrier function in absence of alterations to the intestinal permeability, leading to the 
translocation of bacteria such as Escherichia coli (Maresca et al., 2008). One could thus 
expect that this finding might not only be limited to microbiota present in the gut, but might 
also influence the intestinal phase of the pathogenesis of some adhesive-invasive 
enteropathogenic bacteria such as Salmonella Typhimurium.  
The invasion of the bacterium in the intestinal epithelium is an important step in the intestinal 
phase of a Salmonella Typhimurium infection. Factors enhancing this essential step might 
thus lead towards a higher bacterial load of the gut. Our in vitro studies on porcine intestinal 
epithelial cells showed that pre-exposure to non-cytotoxic concentrations of DON rendered 
the intestinal monolayer more susceptible to invasion by Salmonella Typhimurium, with a 
subsequent enhanced translocation of the bacterium through an intact intestinal monolayer. 
The finding that there was an enhanced Salmonella invasion in and translocation through the 
intestinal epithelium at levels of DON plausibly present in the porcine gut lumen after intake 
of commonly encountered contamination levels in feeding-stuffs, questions the current 
guidance values (European Commission, 2006). Indeed, whereas the intake of feed according 
to these guidance levels will probably not lead to acute clinical symptoms in the pig, the 
effects of subclinical doses have clearly been neglected up till now.  
Prudence however is in order when extrapolating in vitro results to in vivo situations. In vitro 
experiments might overestimate the risk due to mycotoxins as they do not take into account in 
vivo factors able to reduce the final exposure levels, e.g. the degrading capacity of bacteria 
present in the gut lumen. On the other hand, the single mycotoxin exposure mimicked in vitro 
does not totally reflect the in vivo situation where multiple contamination poses an important 
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issue (Grenier and Oswald, 2011) and synergistic actions between different mycotoxins might 
produce even more detrimental effects in the animal. 
 
DON and Salmonella Typhimurium: united enemies of the immune system? 
 
The interaction between DON and Salmonella Typhimurium on the innate immune system 
was illustrated in this thesis, not only at the level of the intestinal epithelial cell-derivate 
immune defence, but also at the level of the macrophage.  
The capacity of some mycotoxins, including DON, to alter inflammation, cellular and 
humoral immune responses was reviewed by Oswald et al. (2005). The consequences of the 
immunomodulation by DON in farm animals comprise both the animal health as public health 
level as this might decrease resistance to infectious disease, reactivate chronic infection or 
reduce vaccine and therapeutic efficacy. 
Using a porcine ligated intestinal ileal loop model, we were able to demonstrate that DON at 
low and relevant intestinal concentrations enhanced the intestinal inflammatory response to 
Salmonella Typhimurium. Exposure of the ileal loops to DON alone did not alter the mRNA 
expression level of any cytokine and chemokines tested. Together with the in vitro finding 
that DON rendered the intestinal epithelium more susceptible to invasion and translocation of 
Salmonella Typhimurium, one could suggest that intake of DON contaminated feed might 
increase the host’s susceptibility to the pathogen.  
By promoting inflammation, the innate immune system attempts to defend the host against 
e.g. invading pathogens. The intestinal lumen is colonized by a dense bacterial community 
called microbiota which protects efficiently against intestinal colonization by most enteric 
pathogens. Normally an infection with Salmonella Typhimurium generates an immune 
response that clears the infection within less than a week. However, it seems that Salmonella 
Typhimurium is able to trigger intestinal inflammation to create specific growth conditions in 
the intestinal lumen, which enable it to outcompete the resident microbiota, leading to gut 
colonization (Stecher et al., 2007; reviewed by Santos et al., 2009). The ability of DON to 
enhance this intestinal inflammatory response when co-exposed to Salmonella Typhimurium, 
together with the fact that intake of DON contaminated feed modifies the dynamics of 
intestinal bacterial communities (Wache et al., 2009), suggests an additional role of DON in 
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turning the balance towards Salmonella Typhimurium and in enhancing pro-inflammatory 
stimulation in gut epithelia (Figure 1).  
 
 
Figure 1: The crosstalk between ribotoxic stress and enteric bacteria. In the normal healthy host intestine 
beneficial interactions between the intestinal mucosa and the enteric commensals mediate mucosal tolerance and 
colonization resistance against incoming pathogenic bacteria. Pathogenic bacteria such as Salmonella employ 
specific virulence factors to trigger intestinal inflammation which can alter the luminal conditions and shift the 
growth competitionwith the commensals in favor of the pathogen. Intake of DON can affect the bacterial 
diversity and richness in the lumen but can also lead to pro-inflammatory ribotoxic insults. Pathogenic situations 
are associated with the pro-inflammatory stimulation by co-exposure to mucosal ribotoxic stress and enteric 
pathogens overwhelming the mucosal tolerance (adapted from Stecher et al., 2007; Moon, 2012). 
 
Although the importance of the systemic phase of a Salmonella Typhimurium infection in 
pigs is still questioned, macrophages appear to play an important role in the long term 
persistence of the bacterium in the gut and gut associated lymphoid tissues (Boyen et al., 
2006, 2009). Pre-exposure of porcine macrophages to DON resulted in a Salmonella 
Pathogenicity Island-1 (SPI-1) independent increased uptake of Salmonella Typhimurium, as 
proven by using a non-invasive strain (ΔsipB). Again, this observation occurred after 
exposure of macrophages to a concentration of DON that is fairly low yet measurable in both 
serum and gastrointestinal tissues after consumption of DON contaminated feed.  
As illustrated in this thesis with Salmonella Typhimurium, DON might possibly increase the 
susceptibility of pigs to infectious disease with subsequent reduced productivity. From public 
health point of view, an increased animal colonization with Salmonella Typhimurium may 
result in increased animal-to-human transmission.  
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DON and Salmonella Typhimurium: close collaboration in enhancing bacterial 
engulfment 
 
The induction of dramatic cytoskeletal changes on the membrane surface of epithelial cells 
and macrophages is a hallmark of invasive Salmonella Typhimurium, in order to establish its 
entry into the cells. After binding to the surface of a macrophage, Salmonella Typhimurium 
induces generalized membrane ruffling that results in the internalization of the bacterium into 
the spacious phagosome (Aderem et al., 1999).  
When exposing macrophages to a concentration of DON that led to an enhanced uptake of 
Salmonella Typhimurium, this coincided with a membrane ruffling formation analogous to 
those seen at bacterial engulfment induced by SPI-1 encoded Type 3 Secretion System (T3SS) 
of Salmonella Typhimurium. This finding suggests a synergistic action between the 
mycotoxin and Salmonella Typhimurium in the bacterial invasion. By activating the mitogen-
activated protein kinase (MAPK) cascade, in particular extracellular signal-regulated kinase 
(ERK) 1/2, DON appears to be able to enhance the uptake of Salmonella Typhimurium 
through membrane ruffling formation. As this concentration of DON did not induce apoptosis 
nor necrosis of the macrophage, this might suggest that DON could enhance the long term 
persistence of Salmonella Typhimurium in macrophages, although the role of macrophages in 
persistent colonization of pigs is still under debate.  
Clearly, it cannot be denied that low non-cytotoxic concentrations of DON can affect the 
interaction of Salmonella Typhimurium with both the intestinal epithelial cell and the 
macrophage, in terms of an increased host cell susceptibility to the pathogen. However, one 
could assume that the toxin’s effect might not only be limited to the eukaryotic cells but could 
also comprise the bacterium. Although exposure to even high concentrations of DON did not 
seem to affect the growth of Salmonella Typhimurium in itself, microarray analysis on the 
effect of DON on the gene expression of Salmonella Typhimurium revealed a general 
downregulation of the bacterium’s metabolism and an increased expression of multidrug 
efflux systems. The effect of DON on the expression of genes involved in virulence and 
motility however, was limited. It appears thus that in the interaction with the pathogenesis of 
Salmonella Typhimurium infections, the effect of DON is more oriented towards the host 
cells than towards the bacterium. As knowledge on the effects of trichothecenes, or 
mycotoxins in general, on prokaryotic cells is scarce, not to say unexisting, this possible 
bacterial intoxication should be kept in mind when studying the interaction between other, 
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more potent toxins and pathogens. Indeed, research performed at our department on the 
interaction between T-2 toxin and the pathogenesis of a Salmonella Typhimurium infection in 
pigs showed that the effect of T-2 toxin was more pronounced on the level of the bacterium 
than at the host cell (Verbrugghe et al., 2012) and this was seen at T-2 toxin contamination 
levels (0.01 and 0.1 mg/kg) measured in swine feed in field situations (Monbaliu et al., 2010). 
 
DON and Salmonella Typhimurium: could they call the tune in Inflammatory Bowel 
Disease? 
 
Many gastrointestinal disorders including inflammatory bowel diseases (IBD) have been 
associated with mucosal intolerance derived from disruption of the epithelial barrier (Park et 
al., 2010). A recent systematic review illustrated that the incidence and prevalence of IBD are 
increasing with time and in different regions around the world, indicating its emergence as 
global disease (Molodecky et al., 2011). Genetic factors play an important role in the disease 
development although it appears that environmental factors might play an important 
etiological role. There is mechanistic evidence that the ribotoxic stress-induced cellular 
responses, as can be seen after intake of DON contaminated food, could be involved as 
critical etiological factors in mucosa-associated diseases, in particular epithelial inflammatory 
diseases (Maresca and Fantini, 2010; Moon, 2012). Moreover, enteric infections with e.g. 
Salmonella have also been suggested to play an etiological role in the development of IBD, 
triggering an already altered immune response or a defect in downregulation of the immune 
response, hence leading to the typical chronic intestinal inflammation seen with IBD (Helms 
et al., 2006; Gradel et al., 2009; Jess et al., 2011).  
Considering these facts above, the interaction between DON and Salmonella Typhimurium 
seen at both the intestinal epithelial cell level as macrophage level, might be rather alarming 
as this inflammatory crosstalk between enteric bacteria and ribotoxic stress can enhance pro-
inflammatory responses and subsequent disorders.  
 
There’s no end to the mycotoxin’s menace 
 
Regulations relating to mycotoxins levels in food and feed have been established in many 
countries in order to ensure the health of both consumers and animals. However, the 
shortcoming of these regulations is that they are primarily based on known and particularly 
acute toxic effects of a single mycotoxin. Step by step it becomes clear that the subtle toxicity 
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of chronic low doses could be more pronounced than initially thought. These effects might 
even be more detrimental for pronounced cytotoxic trichothecenes such as T-2 toxin, for 
which, apart from provisional maximum tolerable daily intake (PMTDI) levels, no maximal 
doses in food or feed have been established yet (Maresca and Fantini, 2010). The fact that 
mycotoxins seldom occur as single contaminant also questions the applicability of the 
proposed safety levels.  
Several pitfalls might be encountered when studying mycotoxicoses, starting at the level of 
food and feed analysis. Factors as inadequate sampling and the presence of masked or 
conjugated forms of mycotoxins that might escape the routine analysis, but could still present 
a risk after being enzymatically hydrolyzed in the gut, might also lead to an underestimation 
of correct values. Further research on the effects of these mycotoxins for animal and human 
health is thus required.  
When assessing the risk associated with mycotoxin exposure, one should be aware that 
although the hazard is more or less the same all over the world, exposure varies due to 
different levels of contamination and dietary habits in the various parts of the world (van 
Egmond et al., 2007). Indeed, the presence of mycotoxins in food is often overlooked in 
developing countries due to public ignorance about their existence, lack of regulatory 
mechanisms, dumping of food products and the introduction of contaminated commodities 
into the human food chain during chronic food shortage due to various factors (Wagacha et 
al., 2008). This puts these low-income countries at high risk to the toxic effects of various 
mycotoxins with besides the direct health risk, enormous economic losses.  
In this context, the development of validated biomarkers for mycotoxin exposure can be very 
useful. Up till now only few biomarkers have been validated for some specific mycotoxins, 
whereas more than 25 mycotoxins are frequently reported to contaminate foodstuff. 
Biomarkers of exposure for DON include the parent compound or glucuronide conjugate 
(Meky et al., 2003; Turner et al., 2008) whereas the clinical relevant growth related proteins 
insulin-like growth factor acid labile subunit (IGFALS) and the insulin-like growth factor 1 
(IGF1) are potential biomarkers of effect (Riley et al., 2011). These detection tools for 
mycotoxin exposure can play a critical role in the effort to reduce the existing uncertainty in 
risk assessment of the most prevalent mycotoxins in humans but also in developing a better 
understanding of the impact of mycotoxin exposure on farm animal productivity (Baldwin et 
al., 2011; Riley et al., 2011).  
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Future research perspectives 
 
Implications of the interaction between DON and Salmonella Typhimurium for public 
health 
The results of the studies described in this thesis indicate that, when exposed to low and 
subclinical concentrations of DON, the porcine host becomes more susceptible to Salmonella 
Typhimurium infections. This enhanced susceptibility could lead to a higher infection level in 
the herd, posing a higher public health risk for salmonellosis through the consumption of 
contaminated pork meat. Moreover, since the intake of DON contaminated feed is known to 
cause in the pig an abdominal distress syndrome associated with a reduced feed intake, one 
could assume that this period of stress could induce re-excretion of Salmonella in 
asymptomatic carrier pigs. Indeed, it has been described that a natural stress stimulus like feed 
withdrawal causes recrudescence of a Salmonella Typhimurium infection in carrier pigs 
(Verbrugghe et al., 2011).  
Porcine in vivo trials combining a chronic exposure to DON-contaminated feed with an 
experimental infection of Salmonella Typhimurium are necessary to investigate these 
assumptions. 
 
Involvement of DON in human IBD 
In order to determine the direct role of DON and trichothecene mycotoxins in general as 
mechanistic mediators in human IBD, toxicological risk assessments are needed. Therefore, 
DON or DON-glucuronide as biomarkers of exposure could be assessed in the human body 
and in specimens (urine) of normal and clinically diseased groups. 
Another interesting aspect in the development of IBD is the involvement of the ATP-binding 
cassette protein (ABC) transporter P-glycoprotein (P-gp). Using knockout mice, a relationship 
between the downregulation of P-gp and the development of IBD has been demonstrated 
(Panwala et al., 1998) and this reduced expression of P-gp was also observed in intestinal 
biopsies obtained from patients with gastrointestinal disorders (Blokzijl et al., 2007). 
Although some ABC transporters including P-gp are used by intestinal epithelial cells to 
export ribotoxic trichothecenes (Tep et al., 2007; Videmann et al., 2007), no information is 
available on whether the intake of mycotoxin contaminated food or feed could modulate the 
expression of these ABC transporters. Recent studies described a role of P-gp in bacterial 
attachment to human gastrointestinal cells (Crowe et al., 2011) as well as the capacity of 
Salmonella Typhimurium to functionally downregulate the efflux capabilities of P-gp 
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(Siccardi et al., 2008). Interestingly, the results of our micro-array analysis showed that 
exposure of Salmonella Typhimurium to DON led to an increased expression of emrAB 
multidrug efflux systems in the bacterium, indicating, at least on prokaryotic level, the 
potential of DON to affect the expression of efflux systems. In this context, investigating the 
effect of both DON and co-exposure of DON and Salmonella Typhimurium on the expression 
and function of P-gp could offer valuable information, to gain not only better insights in the 
pathogenesis but also in the treatment and prevention of environmentally-linked human IBD. 
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The intake of deoxynivalenol (DON) contaminated food and feed as well as salmonellosis are 
ever-growing problems, not only in pig production because of their impact on animal health 
and productivity but also from public health perspective. The high sensitivity to the toxic 
effects of DON together with the high exposure level resulting from their cereal rich diet, sets 
the pig in an extremely vulnerable position toward the intake of DON through the feed. The 
European Union suggested a concentration of 0.9 mg/kg DON as a guidance value in 
complete feed and feedingstuffs for pigs (2006/576/EG). Salmonellosis remains one of the 
most important bacterial zoonoses worldwide and the importance of human Salmonella 
Typhimurium infections through the consumption of contaminated pork meat and derived 
products is still increasing. Although Salmonella Typhimurium infections in pigs can lead to a 
self-limiting enteritis, septicemia and death, most of the infections in pigs are subclinical. The 
latter can be persistently infected, thus posing an important source of contamination for the 
human food chain.  
 
The inhibition of the protein synthesis and the activation of mitogen-activated protein kinases 
(MAPKs) in a process called the ‘ribotoxic stress response’, is the underlying mechanism for 
the toxicity of DON. Although these molecular mechanisms of toxicity can affect numerous 
organs and tissues, the rapidly dividing and differentiating intestinal epithelial cells and the 
macrophages, both being important components of the innate immune response, are extremely 
sensitive to the effects of DON. Because of the importance of these cells in the pathogenesis 
of a Salmonella Typhimurium infection in the pig, the overall aim of this thesis was to 
investigate whether co-occurrence of both DON and Salmonella Typhimurium may result in 
altered interactions between Salmonella Typhimurium and the porcine host.  
 
In chapter one, the effects of low concentrations of DON on the intestinal phase of a 
Salmonella Typhimurium infection in the pig were examined. 
In a first series of experiments, a polarized porcine intestinal epithelial cell model was used to 
examine whether the ability of Salmonella Typhimurium to invade in and translocate through 
the intestinal monolayer was affected after pre-exposure to DON. A distinction was made 
between actively dividing undifferentiated and fully differentiated intestinal epithelial cells, as 
these both cell populations are present in the gut. Concentrations of DON higher than 0.1 
µg/mL had a significant cytotoxic effect on actively dividing cells, whereas concentrations of 
DON up to 10 µg/mL did not affect the viability of the fully differentiated cells. Pre-exposure 
to non-cytotoxic concentrations of DON not only promoted the invasion of Salmonella 
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Typhimurium in the intestinal epithelial cells but also led to an increased translocation of 
Salmonella through the intestinal epithelial monolayer without affecting the integrity of the 
cell monolayer.  
 
Secondly, a porcine intestinal ileal loop model was used to study the effect of DON on the 
intestinal inflammatory response induced by Salmonella Typhimurium by analyzing the 
intestinal cytokine response. A real-time quantitative PCR was developed to quantify a series 
of 8 cytokines and chemokines (IL-1β, IL-6, IL-8, IL-12, IL-18, TNFα, IFNγ and MCP-1), all 
of them involved in the early intestinal immune response. Co-exposure of the ileal loops for 6 
hours to 1 µg/mL of DON and Salmonella Typhimurium resulted in a potentiated intestinal 
immune response in comparison to loops incubated with Salmonella Typhimurium only. This 
was shown by the significant higher gene expression of TNFα and IL-12 and an increase in 
IL-1β, IL-6, IL-8 and MCP-1. Exposure to 1 µg/mL of DON without Salmonella 
Typhimurium did, however not affect the expression level of any cytokine and chemokine 
tested.  
 
In a third experiment, the effect of DON on the gene expression of Salmonella Typhimurium 
was performed using a Salsa Salmonella serovar microarray, covering 5080 genes. This 
revealed that exposure of the logarithmic phase cultures of Salmonella Typhimurium to 0.250 
µg/mL of DON, caused a differential expression of 159 genes. These included, apart from a 
general reduction in the expression of genes involved in energy production, also an increased 
expression of emrAB multidrug efflux systems. These findings could indicate a possible toxic 
effect of DON on the bacterium, but also an attempt of the bacterium to enhance the 
elimination of the toxin. The expression level of only six genes of possible importance in the 
pathogenesis of a Salmonella infection was affected by exposure to DON, including three 
genes (marT, fidL and cigR) with no described significant role for the virulence of Salmonella 
Typhimurium. Three other downregulated genes were involved either in the flagellar 
biosynthesis (fliD and flgL) or in the invasion of  Salmonella Typhimurium in epithelial cells 
(sipA). No changes in gene expression were seen when exposing the stationary phase cultures 
of Salmonella Typhimurium to DON.  
Taking together these results indicate that for the intestinal phase of a Salmonella 
Typhimurium infection, the action of DON is more likely to occur on the intestinal epithelial 
cell level than on Salmonella.   
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In the second chapter, the effect of exposure to DON on the systemic phase of infection was 
mimicked, by studying the uptake and intracellular proliferation of Salmonella Typhimurium 
in DON treated porcine pulmonary alveolar macrophages. Experiments showed that 
concentrations of DON, even up to 50 µg/mL did not affect the growth of Salmonella 
Typhimurium and that Salmonella Pathogenicity Island (SPI)-1 and SPI-2 virulence gene 
expression was only increased after exposure to concentrations of DON higher than 5 µg/mL. 
To exclude a direct cytotoxic effect of DON on the macrophages when studying the host-
pathogen interactions, a non-cytotoxic concentration of DON (0.025 µg/mL) was selected. 
Even though this concentration is low, it is still relevant in practical situations. Pre-exposure 
of macrophages to 0.025 µg/ml of DON enhanced the uptake of Salmonella Typhimurium, 
which was confirmed by microscopic evaluation using a green fluorescent protein expressing 
strain of Salmonella. Similar results were obtained using the ΔSipB strain, indicating that this 
enhanced uptake seen after exposure of macrophages to DON, was not SPI-1dependent. The 
proliferation rate of Salmonella Typhimurium in macrophages was however not affected by 
pre-exposure to DON.  
 
Morphological examination of macrophages treated with 0.025 µg/mL of DON demonstrated 
marked alterations of the cell membrane on Haemacolor staining when compared to untreated 
control macrophages. Additional fluorescence staining with phalloidin-Texas Red
®
, a specific 
probe for polymerized actin, showed an increased ruffling of the macrophage cell membrane 
by reorganization of F-actin after exposure to DON, and this morphological change was not 
associated with apoptosis nor necrosis. By using a specific extracellular signal-regulated 
kinase (ERK)1/2 activator and inhibitor, we demonstrated that this modulation of the 
cytoskeleton of porcine macrophages by DON was due to the activation of this specific 
MAPK family member, which is also described to play a role in the invasion of Salmonella 
Typhimurium in macrophages. In conclusion, these results propose a specific mode of action 
of DON to alter the morphology of macrophages, enhancing the uptake of Salmonella 
Typhimurium in this cell population.   
To our knowledge, this is the first study describing an interaction between the mycotoxin 
DON and the pathogenesis of a Salmonella Typhimurium infection in the pig.  
The results of this thesis clearly demonstrate that exposure to DON affects the interaction of 
the bacterium with both the intestinal epithelial cell and the macrophage, and through this 
renders the porcine host more susceptible to a Salmonella Typhimurium infection. The fact 
that these host-pathogen interactions occur at low and non-cytotoxic concentrations of DON, 
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stresses the need for further research on the toxicity of long term exposure to low doses of 
DON on both animal and human health.  
Although this being a theoretical statement, the finding that exposure to DON leads to an 
enhanced invasion and translocation of Salmonella Typhimurium through an intact intestinal 
epithelium could offer perspectives in the research on the development of chronic intestinal 
inflammatory disease or IBD, in which both the intake of DON contaminated food and 
infections with Salmonella are put forward as potential etiological factors.  
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Zowel de opname van voeder gecontamineerd met deoxynivalenol (DON) als salmonellose 
zijn in belang toenemende problemen, niet alleen in de varkensindustrie omwille van hun 
impact op de diergezondheid en productiviteit, maar ook omwille van hun risico voor de 
volksgezondheid. De hoge gevoeligheid voor de toxische effecten van DON, samen met het 
hoge blootstellingsrisico dat voorvloeit uit hun graanrijke dieet, maakt het varken tot één van 
de gevoeligste diersoorten voor de opname van DON via het voeder. De Europese Unie legde 
0.9 mg/kg DON vast als richtwaarde voor aanvullende en volledige dierenvoeders voor 
varkens (2006/576/EG).  Salmonellose blijft wereldwijd één van de belangrijkste bacteriële 
zoönosen en het belang van Salmonella Typhimurium infecties als gevolg van de consumptie 
van besmet varkensvlees en afgeleide producten neemt alleen maar toe. In een aantal 
zeldzame gevallen kunnen infecties met Salmonella Typhimurium leiden tot een 
zelflimiterende enteritis, septicemie en sterfte, de meeste infecties bij het varken blijven 
echter subklinisch. Nochtans kunnen deze varkens blijvend geïnfecteerd zijn en bijgevolg een 
belangrijke besmettingsbron vormen voor de menselijke voedselketen.  
Het werkingsmechanisme van DON berust niet enkel op een inhibitie van de eiwitsynthese, 
het toxine is eveneens in staat om mitogen-activated protein kinases (MAPKs) te activeren via 
een mechanisme dat gekend is als ‘ribotoxic stress reponse’. Hoewel het toxine op deze 
manier de functie van diverse organen en weefsels kan beïnvloeden, blijken zowel de 
sneldelende intestinale epitheliale cellen als de macrofagen, een belangrijk celtype in het 
aangeboren immuunsysteem, uitermate gevoelig voor de schadelijke effecten van DON. Deze 
cellen spelen bovendien een belangrijke rol in de pathogenese van Salmonella Typhimurium 
infecties bij het varken. Daarom was het hoofddoel van dit onderzoek om na te gaan of 
gelijktijdig voorkomen van zowel DON als Salmonella Typhimurium een invloed zou kunnen 
hebben op de interactie tussen Salmonella Typhimurium en het varken. 
In hoofdstuk 1 werd het effect van lage concentraties DON op de intestinale fase van een 
Salmonella Typhimurium infectie bij het varken bestudeerd.  
In een eerste reeks experimenten werd een gepolariseerde intestinale varkensepitheelcellijn 
gebruikt om na te gaan of het vermogen van Salmonella Typhimurium om te invaderen in en 
te transloceren doorheen een intestinale cellulaire monolaag, beïnvloed werd door 
voorbehandeling met DON. Hierin werd een onderscheid gemaakt tussen ongedifferentieerde 
actief delende cellen en volledig gedifferentieerde intestinale epitheelcellen, gezien deze 
celpopulaties aanwezig zijn in de darm. Er werd aangetoond dat DON concentraties hoger dan 
0.1 µg/mL een significant cytotoxisch effect hadden op de actief delende cellen, terwijl DON 
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concentraties tot 10 µg/mL geen invloed hadden op de leefbaarheid van volledig 
gedifferentieerde cellen.  Voorbehandeling met niet-cytotoxische concentraties DON zorgde 
niet alleen voor een verhoogde invasie van Salmonella Typhimurium in de intestinale 
epitheelcellen, het leidde eveneens tot een verhoogde passage van Salmonella doorheen de 
epitheliale celmonolaag zonder aantasting van de integriteit van deze monolaag.  
Vervolgens werd een varkensdarmlusmodel gebruikt om, via analyse van de intestinale 
cytokine respons, de invloed van DON na te gaan op de intestinale ontstekingsreactie 
geïnduceerd door Salmonella Typhimurium. Hiertoe werd een kwantitatieve PCR methode 
ontwikkeld om een reeks van 8 cytokines en chemokines (IL-1β, IL-6, IL-8, IL-12, IL-18, 
TNFα, IFNγ en MCP-1), elk betrokken bij de vroege intestinale immuunreactie, te 
kwantificeren. Gelijktijdige blootstelling van ileale darmlussen gedurende 6 uur aan 1 µg/mL 
DON en Salmonella Typhimurium resulteerde in een versterkte intestinale immuunreactie in 
vergelijking met loops die enkel waren geïncubeerd met Salmonella Typhimurium. Dit werd 
aangetoond door de significant hogere genexpressie van TNFα en IL-12, en een verhoging 
van IL-1β, IL-6, IL-8 en MCP-1. Het expressiegehalte van geen enkel getest cytokine en 
chemokine werd echter beïnvloed door blootstelling aan 1 µg/mL DON alleen. 
In een derde experiment werd het effect van DON op de genexpressie van Salmonella 
Typhimurium zelf nagegaan, door middel van een Salsa Salmonella serovar microarray, die 
5080 genen omvat. Blootstelling van logaritmische fase culturen van Salmonella 
Typhimurium aan 0.250 µg/mL DON veroorzaakte een veranderd expressiepatroon van 159 
genen. Deze omvatten, naast een algemene reductie van de expressie van genen betrokken in 
de energieproductie, ook een verhoogde expressie van emrAB multidrug efflux systemen. 
Deze bevindingen kunnen wijzen op een mogelijk toxisch effect van DON op de kiem, maar 
eveneens op een poging van de kiem om het toxine te elimineren. Het expressie patroon van 
slecht zes genen van mogelijk belang in de pathogenese van een Salmonella infectie werd 
beïnvloed door blootstelling aan DON, waaronder drie genen (marT, fidL en cigR) met een 
beperkte rol in de virulentie van Salmonella Typhimurium. Drie andere onderdrukte genen 
waren ofwel betrokken in de flagellaire biosynthese (fliD en flgL) ofwel in de invasie van 
Salmonella Typhimurium in epitheelcellen (sipA). Er werden geen veranderingen gezien in 
het genexpressie patroon bij blootstelling van stationaire fase culturen van Salmonella 
Typhimurium aan DON.  
  Samenvatting 
 
147 
 
Samengevat tonen deze resultaten aan dat voor de intestinale fase van een Salmonella 
Typhimurium infectie, het effect van DON wellicht meer uitgesproken is op het niveau van de 
epitheelcellen dan op Salmonella. 
In het tweede hoofdstuk werd het effect van DON op de macrofaag nagegaan, door de 
opname en intracellulaire vermeerdering van Salmonella Typhimurium te bestuderen in 
varkensmacrofagen die werden voorbehandeld met DON. Experimenten toonden aan dat hoge 
concentraties DON tot 50 µg/mL geen effect hadden op de groei van Salmonella 
Typhimurium en dat de expressie van virulentiegenen gelegen op de Salmonella 
Pathogeniciteitseilanden SPI-1 en SPI-2 (Salmonella Pathogenicity Islands; SPI) enkel werd 
verhoogd door concentraties DON hoger dan 5 µg/mL. Om een direct cytotoxisch effect van 
DON op de macrofagen uit te sluiten bij het bestuderen van de kiem-gastheer interacties, werd 
een niet-cytotoxische concentratie van DON (0.025 µg/mL) geselecteerd met behulp van een 
cytotoxiciteitstest. Hoewel deze concentratie laag is, blijkt ze toch nog van belang in 
praktijksituaties. Voorafgaandelijke blootstelling van macrofagen aan 0.025 µg/mL DON 
bevorderde de opname van Salmonella Typhimurium bacteriën, wat microscopisch werd 
bevestigd met behulp van een groen fluorescente Salmonella stam. Gelijkaardige resultaten 
werden bekomen met de deletiemutant in het sipB gen, hetgeen aantoonde dat de verhoogde 
opname na blootstelling van de macrofagen aan DON, SPI-1 onafhankelijk was. De 
vermeerderingsratio van Salmonella Typhimurium in macrofagen werd echter niet beïnvloed 
door voorafgaandelijke blootstelling aan DON. 
Morfologisch onderzoek na Haemacolor kleuring van DON behandelde macrofagen toonde 
opmerkelijke veranderingen aan de celmembraan wanneer deze werden vergeleken met 
onbehandelde controle macrofagen. Bijkomende fluorescente kleuringen met phalloidine-
Texas Red
®
, een specifieke probe voor gepolymeriseerd actine, toonde een verhoogde rafeling 
van de celmembraan van de macrofagen ten gevolge van een reorganisatie van F-actine na 
blootstelling aan DON. Deze morfologische verandering bleek niet geassocieerd te zijn met 
apoptose of necrose. Door gebruik te maken van een specifeke extracellular signal-regulated 
kinase (ERK)1/2 activator en inhibitor werd aangetoond dat deze cytoskeletale verandering 
van de varkensmacrofaag door DON te wijten was aan de activatie van dit specifiek eiwit van 
de MAPK familie. Dit eiwit speelt bovendien een rol in de opname van Salmonella 
Typhimurium in de macrofagen. Samengevat suggereren deze resultaten een specifiek 
werkingsmechanisme van DON om de morfologie van macrofagen te veranderen, hetgeen 
kan leiden tot een verhoogde opname van Salmonella Typhimurium in deze celpopulatie. 
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Voor zover bekend, is dit de eerste studie die een interactie beschrijft tussen het mycotoxine 
DON en de pathogenese van een Salmonella Typhimurium infectie bij het varken. 
De resultaten van dit proefschrift tonen duidelijk aan dat blootstelling aan DON de interactie 
van de kiem met zowel de intestinale epitheliale cel als met de macrofaag beïnvloedt en het 
varken hierdoor meer gevoelig wordt voor een infectie met Salmonella Typhimurium. Het feit 
dat deze kiem-gastheer interactie voorkomt bij lage en niet-cytotoxische concentraties DON 
benadrukt de nood aan verder onderzoek naar de schadelijke effecten van chronische 
blootstelling aan lage concentraties DON voor de gezondheid van mens en dier.  
Hoewel speculatief, zou de bevinding dat blootstelling aan DON leidt tot een verhoogde 
invasie en passage van Salmonella Typhimurium doorheen een intact intestinaal epitheel, 
perspectieven kunnen bieden in het onderzoek naar de ontwikkeling van chronische 
darmontstekingen zoals IBD, daar zowel de opname van DON gecontamineerd voedsel als 
infecties met Salmonella voorgesteld worden als mogelijke etiologische factoren voor dit 
ziektebeeld. 
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En dan is het enige wat er nog moet gebeuren om dit boekje en bijhorend doctoraatsonderzoek 
af te ronden, een dankwoord schrijven. Gemakkelijke opdracht, niet? Niets is minder waar, 
aangezien zoveel mensen, elk op hun manier hebben bijgedragen tot dit werk wat vandaag 
voor u ligt, en elk van hen hiervoor een woord van dank meer dan verdient. 
Uiteraard kon dit doctoraatsonderzoek niet tot een goed einde worden gebracht zonder de 
steun van mijn twee promotoren Prof. Dr. Croubels en Prof. Dr. Pasmans. Siska, zes jaar 
geleden ben ik bij u gestart als assistent in de toxicologie en zette ik de eerste stappen in het 
mycotoxine onderzoek. Je nam altijd de tijd om alles nauwgezet door te nemen, en de puntjes 
op de i te zetten. Ik wil je graag bedanken voor de steun en het vertrouwen gedurende de 
voorbije zes jaar. Frank, voor het Salmonella luik kon ik steeds op jou rekenen. Bedankt voor 
jouw eerlijke, kritische inbreng in dit onderzoek.  
Professor De Backer en Professor Haesebrouck wil ik graag bedanken, niet alleen om mij de 
kans te geven dit onderzoek binnen hun vakgroep uit te voeren, maar ook voor hun 
wetenschappelijke ondersteuning gedurende mijn doctoraatsjaren.  
De leden van de begeleidings- en examencommissie, Prof. Dr. Gasthuys, Prof. Dr. Maes, 
Prof. Dr. Janssens, Dr. Imberechts, Dr. Oswald, Dr. Maresca en Dr. Boyen wil ik graag 
bedanken voor hun nuttige opmerkingen en suggesties. Dr. Oswald, thank you for making 
time to come over from Toulouse to attend my PhD defence. Dr. Maresca, thank you for your 
interest in my research. I wish you both the very best in your further mycotoxin research. 
Filip, niet alleen als lid van de examenjury, maar gedurende het hele doctoraatsonderzoek kon 
ik steeds bij jou terecht voor een update over de laatste nieuwe Salmonella literatuur of 
nieuwe suggesties voor experimenten. Bedankt hiervoor.  
Joline, jij was de eerste die mij kwam vergezellen in het mycotoxine onderzoek. ‘Enkele 
varkensproefjes’ verder , kan jij ook beginnen afronden. Je zal dat prima doen en als het 
allemaal wat tegen zit, dan ga je toch gewoon even ‘de beentjes strekken’ in de Vlaamse 
Ardennen! Ik bewonder jouw doorzettingsvermogen, je bent een straffe madam! Ann, kippen 
jagen je ondertussen al lang geen schrik meer aan! Ondertussen staat jou een heel andere 
uitdaging te wachten maar ook deze zal je zonder twijfel prima aanpakken. Vergeet ons motto 
niet: we leven maar één keer (en daar eten we graag nog een chocolaatje op)! En 
Mathias…chapeau! Jij houdt je met verve staande in die vrouwenbureau. Veel succes in het 
verdere onderzoek en vergeet niet een kaartje te sturen uit Canada! Anja, de onuitputtelijke 
kracht bij het uitvoeren van talrijke dierproeven, labowerk en nog zoveel meer. Geen 
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weekend- of avondwerk was je teveel, bedankt hiervoor. Elin, of het nu in de stal tussen de 
varkens, aan de flow of op de trein was, we konden altijd wel eens tegen elkaar ventileren 
over onze Salmonella en toxine probleempjes. Maar het belangrijkste is dat we er uiteindelijk 
altijd wel ‘s goed konden mee lachen. Gunther, jij bent er nog maar pas bijgekomen, ik wens 
je veel succes in het verdere Clostridium onderzoek. Het was een plezier om jullie allemaal in 
het mycotoxine-team te hebben, bedankt voor de vele onvergetelijke momenten!  
Voor een toxicologie vraagje, hulp bij een dierproef, een gezellige babbel over de fratsen van 
onze kindjes of om gewoon even stoom af te laten, kon ik steeds terecht bij het LPS-team. 
Anneleen, jouw enthousiasme en levenslust werken aanstekelijk. Elke, bedankt om de 
toxicologie zo goed over te nemen. Heidi, met slechts één dag leeftijdsverschil tussen onze 
(b)engeltjes, hadden we wel iets gemeen. LPS’ers, veel succes in jullie verdere 
doctoraatsonderzoek en bedankt voor alles! 
Ook de biochemie collega’s verdienen een woord van dank. Jella, nog even doorbijten en je 
bent er ook vanaf! Ik verwacht een regelmatige update van die baby-poll! Donna, bedankt 
voor de toffe babbels! Je mag me binnenkort verwachten in Torhout . Kristel, met jouw 
gedrevenheid en enthousiasme zorgt je ervoor dat op de biochemie alles in goede banen loopt. 
Koen, ik wens je veel geslaagde experimentjes toe. Dieter, we zijn een eindje treincollega’s 
geweest, ondertussen ben je ook een nieuwe horizon gaan verkennen. Ik wens je veel geluk 
toe, zowel op werk- als thuisvlak. Prof. Dr. Meyer, Evelyne, bedankt om steeds weer interesse 
te tonen in mijn onderzoek.  
Kris B., niet alleen voor alle toxicologische, dierproef of computergerelateerde probleempjes 
kon ik bij jou terecht, ook voor een babbel had je altijd even tijd. Als het om kwaliteit gaat, 
moet je bij Ann S. zijn. Iedere GLP controle breng jij, hoewel soms met de nodige frustraties, 
steeds weer tot een goed einde. An M., jij zorgt ervoor dat alles in het labo vlot en netjes 
verloopt. Bedankt voor dat luisterend oor en woord van steun als het soms wat moeilijker 
ging. Siegrid, bij vragen over analyses en methode-ontwikkelingen sta jij steeds  klaar om te 
helpen. De Kela collega’s, Marc en Kris DK, hoewel vaak verscholen achter jullie toestel in 
het labo toch steeds klaar voor een tof gesprek. Nathalie, jij hebt jouw handen soms meer dan 
vol met al onze administratieve zaken en het doorverbinden van telefoontjes. Bedankt om dit 
alles toch steeds weer in goede banen te leiden. Jelle, jij hebt de taak van Maggy prima 
overgenomen. Veel succes met de verdere verbouwing van jullie boerderijtje.  
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Ik wil ook graag enkele collega’s van het eerste uur bedanken. Sandra en Tim, mijn eerste 
bureaugenoten, Eva en Barbara, ondertussen zijn jullie al een eindje de ‘echte’ wereld 
ingetrokken maar ik denk nog met plezier terug aan de dubbelzinnige opmerkingen, de leuke 
momenten, opbeurende gesprekken en het hart onder de riem wanneer het eens wat minder 
ging. Karl, ik ga onze zwemmende big in de beerput toch niet snel vergeten...Dieter, voor een 
grap was je nooit ver weg maar ook voor het serieuze slachthuiswerk ’s morgens vroeg kon ik 
op je rekenen. Noël, herinner je nog al die muisjes? Samen hebben we die toch mooi ‘klein’ 
gekregen, hé! Maggy, onze wandelende toxicologie-encyclopedie, de manier waarop jij al die 
jaren de giftige zaakjes in goede banen leidde, kan alleen maar bewonderd worden. Edith, ook 
jij hebt die mooie tijd met jouw kleinkinderen meer dan verdiend! Jullie zorgden er allemaal 
voor dat ik me vanaf dag één welkom voelde op de vakgroep. 
Voor mijn onderzoek heb ik ook een groot deel van mijn tijd doorgebracht op de dienst 
Bacteriologie. Vanaf de eerste dag voelde ik me er goed en ik heb het geluk gehad om te 
mogen samen werken met een groep toffe, enthousiaste mensen! Hoewel sommigen zich 
ondertussen reeds in andere onderzoeksdomeinen hebben verdiept, wil ik graag iedereen 
bedanken die de voorbije jaren deel uitmaakte van de Salmonella varken onderzoeksgroep. 
Ook de mensen van de Pathologie en Pluimveekliniek wil ik bedanken voor hun steun en 
interesse. Prof. Dr. Martel, An, bedankt voor jouw hulp bij het uitvoeren van de 
loopexperimenten. Ieder van jullie heeft, op zijn of haar manier, ervoor gezorgd dat ik met 
plezier zal terug denken aan mijn doctoraatsjaren hier. 
Rosalie, jij hebt me op gang gezet in het Salmonella onderzoek, het was een plezier om met 
jou te mogen samen werken. Ik hoop dat we ook in de toekomst nog dikwijls eens gezellig 
kunnen bijpraten. 
Ook met de leden van de MYTOX en associatie onderzoeksgroep was het steeds fijn 
samenwerken. Ik wil hen graag bedanken voor hun deskundig advies omtrent alle andere 
aspecten, naast diergezondheid, binnen het mycotoxine onderzoek.  
Hoe fijn het ook is om in een aangename stimulerende omgeving jouw werk te mogen 
uitvoeren, zonder de geborgenheid van het thuisfront zou dit alles niet mogelijk geweest zijn. 
Ik wil dan ook graag mijn familie en schoonfamilie bedanken voor hun onvoorwaardelijke 
steun de voorbije jaren.  
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Annelies, onze vriendschap gaat al lang terug en is doorspekt met mooie momenten. Hoewel 
we elkaar soms een heel eind niet zien, het voelt goed om te weten dat je er altijd bent voor 
mij. Ik ben vereerd dat ik meter mag zijn van jullie toekomstige spruit! 
Rudy en Christine, jullie staan altijd klaar om te helpen waar nodig. Stefaan, jij zorgt op tijd 
en stond voor wat groen in onze tuin. Charlotte en kleine Iris, wie weet raken we binnenkort 
wel eens in Spanje voor een portie zonne-energie. Bedankt dat jullie er zijn! 
Mémé Godelieve, ik weet dat je zal opgelucht zijn dat dit achter de rug is. Bedankt voor jouw 
bezorgdheid en steun. 
Mamie en papie, ik weet dat jullie ook enorm naar deze dag hebben uitgekeken. Ik ben jullie 
zeer dankbaar voor alle kansen die jullie mij hebben gegeven en voor het vele geduld dat 
jullie hebben gehad tijdens mijn studies en dit doctoraat. Niets is jullie ooit teveel. Bedankt 
voor alles! 
Wat zou ik doen zonder mijn twee stoere mannen in huis! Philippe en Andreas, jullie hebben 
veel moeten verdragen de laatste maanden. Maar kijk, het is gelukt, dankzij jullie steun en het 
vertrouwen dat alles wel goed ging komen. Jullie maken het allemaal de moeite waard…  
 
"The clock is running. Make the most of today. Time waits for no man. Yesterday is history. 
Tomorrow is a mystery. Today is a gift. That's why it is called the present."  
(Alice Morse Earle) 
 
 
 
